: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

Chinese Coaching

Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Otorhinolaryngology

Free Subscription

Articles published in Oral Oncol
Retrieve available abstracts of 484 articles:
HTML format

Single Articles

January 2026

DAI WF, Nguyen L, Liu N, Chan KK, et al
Real-world effectiveness and healthcare utilization of nivolumab for advanced head and neck cancer: A real-world population-based descriptive study.
Oral Oncol. 2026;173:107851.
PubMed Abstract available

MARGONI A, Papavassiliou KA, Papavassiliou AG
Harnessing TP53 mutational status to enhance prognostic precision and therapeutic effectiveness in head and neck squamous cell carcinoma.
Oral Oncol. 2026;173:107846.
PubMed

WU WJ, An PG, Zhang ZQ, Shen LH, et al
Neoadjuvant tislelizumab plus chemotherapy in locally advanced oral and oropharyngeal squamous cell carcinoma: A single-arm phase II clinical trial.
Oral Oncol. 2026;172:107809.
PubMed Abstract available

NIU S, Ding J, Chen H, Zhu Z, et al
Positron emission tomography-based intratumoral spatial diversity for prognosis in nasopharyngeal carcinoma.
Oral Oncol. 2026;173:107845.
PubMed Abstract available

December 2025

XIAO G, Ning L, Chen L, Zhang S, et al
Exercise and quality of life in head and neck squamous cell carcinoma patients receiving neoadjuvant immuno-chemotherapy: A randomized, open-labeled phase II trial.
Oral Oncol. 2025;173:107844.
PubMed Abstract available

JAKOBSEN KK, H Rasmussen J, Melchiors J, Agander TK, et al
Head and neck cancer trends in Denmark: A nationwide, 40-Year data analysis.
Oral Oncol. 2025;173:107843.
PubMed Abstract available

LECHIEN JR, Paleri V, Baudouin R, Brunet A, et al
European surgical guidelines: transoral robotic surgery for head and neck cancers.
Oral Oncol. 2025;173:107826.
PubMed Abstract available

CHAUDHRY M, Elfar A, Rowsey K, Neel A, et al
Safety reporting in head and neck squamous cell carcinoma clinical Trials: A comparative analysis of ClinicalTrials.gov data and published research.
Oral Oncol. 2025;173:107840.
PubMed Abstract available

ZHANG M, Song J, Yuan Y, Cao X, et al
Ensemble learning-based radiomics model for predicting radiation-induced temporal lobe injury in nasopharyngeal carcinoma.
Oral Oncol. 2025;173:107841.
PubMed Abstract available

PARK SE, Hong SH, Park JO, Kim SY, et al
Head and neck squamous cell carcinoma following allogeneic bone marrow transplantation: Clinical features, genomic Alterations, and limited efficacy of palliative chemotherapy.
Oral Oncol. 2025;173:107827.
PubMed Abstract available

THIAGARAJAN S, Rukmangathan T, Sharma D, Kakade A, et al
Prevalence, risk Factors, and quality of life in patients with head and neck lymphedema following treatment for head and neck Cancer: The HeNLy-1 study.
Oral Oncol. 2025;173:107838.
PubMed Abstract available

LIU Q, Wei JN, Zhou JY, Zhang CR, et al
Development of a simplified scoring system for MRI-detected retropharyngeal lymph node features to optimize AJCC 9th edition N classification in nasopharyngeal carcinoma.
Oral Oncol. 2025;173:107825.
PubMed Abstract available

ZOU C
Letter to the editor: Stroke risk after head and neck cancer diagnosis and treatment in a Real-World clinical cohort.
Oral Oncol. 2025;172:107705.
PubMed

CHOW VL, Ho VW, Lo AS
Trans-hairline robotic neck dissection and robotic microvascular free flap reconstruction in oral cavity cancer.
Oral Oncol. 2025;172:107819.
PubMed Abstract available

YOON HN, Kim JH, Gu D, Lee J, et al
Patient-derived 3D organoid platform for functional assessment of GPC3-targeted CAR T cell cytotoxic activity in head and neck squamous cell carcinoma.
Oral Oncol. 2025;172:107814.
PubMed Abstract available

SHAIKH MH, Gazala W, Zeng C, Naimi MF, et al
NOTCH1 loss promotes chemo and radio-resistance in head and neck cancer.
Oral Oncol. 2025;172:107815.
PubMed Abstract available

HACK S, Attal R, Geva K, Farzad A, et al
Blinded comparative evaluation of GPT-generated, online search-derived, and guideline-based answers for HPV-associated oropharyngeal cancer.
Oral Oncol. 2025;172:107813.
PubMed Abstract available

BARAN E, Lee M, Kamalraj P, Karam I, et al
Cancer stage documentation and accuracy: Single-center retrospective study on oropharyngeal cancers.
Oral Oncol. 2025;171:107795.
PubMed Abstract available

CHELVARAJAH RC, Huang SH, Su J, Gete M, et al
Outcomes and characteristics of patients receiving pre-operative versus post-operative radiotherapy for sinonasal squamous cell carcinoma.
Oral Oncol. 2025;171:107794.
PubMed Abstract available

CHONG CY, Young RJ, Lim AM, Pizzolla A, et al
Evaluating CD103(+) intratumoral immune cell abundance and PD-L1 CPS in primary tumors versus lymph nodes in Human papillomavirus associated oropharyngeal Cancer.
Oral Oncol. 2025;171:107792.
PubMed Abstract available

HIDALGO CM, Hernandez-Herrera GA, Day CN, Olawuni F, et al
Access to surgery and high-quality radiotherapy for human papillomavirus related oropharynx cancer.
Oral Oncol. 2025;171:107768.
PubMed Abstract available

November 2025

LECHIEN JR
Learning process of transoral robotic surgery for head and neck cancers: a scoping review.
Oral Oncol. 2025;171:107788.
PubMed Abstract available

LI M, Zhou Y, Cai M
Letter to the Editor: A phase II clinical trial of paclitaxel-carboplatin as neoadjuvant therapy followed by surgery in patients with locally advanced head and neck squamous cell carcinoma.
Oral Oncol. 2025;171:107784.
PubMed

OKURA M, Yamakawa N, Otsuru M, Hasegawa T, et al
T4a classification for oral cancer using mandibular canal invasion instead of bone marrow invasion in the TNM staging system.
Oral Oncol. 2025;171:107771.
PubMed Abstract available

DOERFLER R, Chen J, Kim C, Smith JD, et al
Integrating artificial intelligence-driven digital pathology and genomics to establish patient-derived organoids as new approach methodologies for drug response in head and neck cancer.
Oral Oncol. 2025;171:107742.
PubMed Abstract available

DIEZ-FRAILE A, Pottel L, Lamoral P, De Backer T, et al
Age and surgical complexity outperform preoperative Geriatric-8 for 30-day major complications in older head and neck cancer.
Oral Oncol. 2025;171:107774.
PubMed

VAN LOOCKE P, Beuselinck B, Meulemans J, Nuyts S, et al
Impact of time-of-day administration of immune checkpoint inhibitors on survival outcomes in patients with recurrent/metastatic head and neck cancer (R/M HNSCC): a retrospective cohort study.
Oral Oncol. 2025;171:107772.
PubMed

TIRELLI G, Boscolo-Rizzo P
Perioperative pembrolizumab and the changing paradigm of adjuvant therapy in head and neck squamous cell carcinoma: the case of T1-2, pN1.
Oral Oncol. 2025;171:107770.
PubMed

MASO V, Lechien JR, Gengler I, Chiesa-Estomba C, et al
Management of head and neck cancer around the world: an international survey by the world ear, nose, and throat federation.
Oral Oncol. 2025;171:107766.
PubMed Abstract available

WILLIAMS MM, Hanna GJ, Sethi RK, Rettig EM, et al
Outcomes of oropharyngeal squamous cell carcinoma among patients with lymphoproliferative disorders.
Oral Oncol. 2025;170:107761.
PubMed Abstract available

LI R, Ma S, Tang T, Zhao Y, et al
Prognostic impact and risk factors of level IV/V lymph nodes metastasis in laryngeal squamous cell carcinoma.
Oral Oncol. 2025;170:107758.
PubMed Abstract available

ZHU AQ, Cassianni CE, Haller T, O'Byrne TJ, et al
Sensitivity of post-treatment surveillance in detecting recurrence and metastasis in surgically treated HPV-positive oropharyngeal squamous cell carcinoma patients.
Oral Oncol. 2025;171:107767.
PubMed Abstract available

October 2025

BERTIN B, Kowalski LP, Matos LL
The low evidence to treat elderly patients with head and neck cancer.
Oral Oncol. 2025;171:107764.
PubMed Abstract available

XIANG N, Li W
Re: "Patterns of care in de?novo oligo?metastatic and oligo?recurrent head and neck cancers: A HNCIG survey" (Oral oncology).
Oral Oncol. 2025;171:107749.
PubMed

DAS R, Misra SR, Mohapatra SSG
Refining prognosis and Personalizing Therapy: A Step Forward with Machine learning in HPV-Associated head and neck cancer.
Oral Oncol. 2025;170:107752.
PubMed

LIANG H, Guo Y
Comment on "Massive nasal bleeding in nasopharyngeal carcinoma": Risk stratification and clinical implications.
Oral Oncol. 2025;170:107755.
PubMed

HELOU V, Abdul-Rahman NH, Loo SK, Gao SJ, et al
Circulating tumor DNA in Non-Viral head and neck squamous cell Carcinoma: A systematic review and Meta-Analysis.
Oral Oncol. 2025;170:107760.
PubMed Abstract available

WANG Q, Yang Q, Wang Z, Duan X, et al
Efficacy of primary lesion re-irradiation in nasopharyngeal carcinoma with synchronous recurrence and distant metastasis.
Oral Oncol. 2025;170:107743.
PubMed Abstract available

KANG SK, Brooks E, Wolk R, Siriruchatanon M, et al
Assessing liquid biopsy tests for the detection of head and neck squamous cell carcinoma: an umbrella review.
Oral Oncol. 2025;170:107535.
PubMed Abstract available

BOIDE A, Glasmacher AR, Wurschi G, Tews AM, et al
Fear of cancer recurrence in adults with p16-positive head and neck cancer after radiotherapy - Results from a multicenter cross-sectional observational study.
Oral Oncol. 2025;170:107757.
PubMed Abstract available

HONG MH, Lee S, Kim CG, Son W, et al
A phase II clinical trial of paclitaxel-carboplatin as neoadjuvant therapy followed by surgery in patients with locally advanced head and neck squamous cell carcinoma.
Oral Oncol. 2025;170:107745.
PubMed Abstract available

JEYARAJ G
Commentary on "Uncovering chromatin factor landscapes in head and neck squamous cell carcinoma".
Oral Oncol. 2025 Oct 10:107741. doi: 10.1016/j.oraloncology.2025.107741.
PubMed

MARUDHUPANDI T
Predictive value of circulating tumor tissue-modified HPV DNA kinetics in induction therapy for oropharyngeal squamous cell carcinoma.
Oral Oncol. 2025;170:107746.
PubMed Abstract available

LI Y, Tong S, Tian J, You X, et al
Comment on: "Feasibility and preliminary efficacy of a lymphedema and fibrosis self-management program for head and neck cancer survivors: A pilot randomized controlled trial".
Oral Oncol. 2025;170:107729.
PubMed

LI S, Garb BF, Qin T, Soppe SE, et al
Tumor subtype classification tool for HPV-associated head and neck cancers.
Oral Oncol. 2025;170:107726.
PubMed Abstract available

SWAIN M, Ghosh-Laskar S, McDowell L, Henson C, et al
Patterns of care in de-novo oligo-metastatic and oligo-recurrent head and neck cancers: A Head and Neck Cancer International Group (HNCIG) Survey.
Oral Oncol. 2025;170:107647.
PubMed Abstract available

VARETA JA, Zhang X, Kuhnell D, Hagen MC, et al
Characterizing the mutational landscape of sinonasal squamous cell carcinoma using whole-exome sequencing.
Oral Oncol. 2025;169:107694.
PubMed Abstract available

HAGREN A, Sjovall J, Brogardh C, Johansson K, et al
Head and neck lymphedema after radiotherapy - Prevalence, changes and associated factors - a prospective observational cohort study.
Oral Oncol. 2025;169:107671.
PubMed Abstract available

HINTZE JM, Cleere E, Timon C, Kinsella J, et al
The lymph node ratio is a prognostic factor for survival in laryngeal and hypopharyngeal squamous cell carcinoma.
Oral Oncol. 2025;169:107625.
PubMed Abstract available

SIQUEIRA JM, Heguedusch D, Cunha MT, de Sousa LG, et al
Exploring TROP2 expression in oropharyngeal squamous cell carcinoma: Association with prognosis and tumor immune microenvironment composition.
Oral Oncol. 2025;169:107634.
PubMed Abstract available

HOUCINE Y, Kedous S, Kamoun S, Methnani A, et al
Nasopharyngeal low-grade papillary Adenocarcinoma: A rare entity with diagnostic challenges.
Oral Oncol. 2025;169:107612.
PubMed Abstract available

KUMARAGURU S, Pandiyan R
Letter to the Editor: Clinical significance of HPV16 in oropharyngeal cancer: a commentary on recent evidence.
Oral Oncol. 2025;169:107550.
PubMed Abstract available

MARUDHUPANDI T
Letter to the Editor: Prospective study of algorithm-based chemoradioselection to optimize treatment intensity for advanced head and neck cancer.
Oral Oncol. 2025;170:107731.
PubMed Abstract available

MARUDHUPANDI T
Letter to the editor: Development of a novel prognostic signature derived from super-enhancer-associated gene by machine learning in head and neck squamous cell carcinoma.
Oral Oncol. 2025;170:107730.
PubMed Abstract available

September 2025

MISRA SR, Das R
Palliative care integration in head and neck Cancer: Bridging the gap between evidence and practice.
Oral Oncol. 2025;170:107735.
PubMed

MISRA SR, Das R, Giri M
Commentary on "pre-treatment PET/CT for head and neck squamous cell carcinoma: secondary analysis of a clinical trial".
Oral Oncol. 2025;170:107701.
PubMed

ANNAMALAI A
Comments on, "Risk factors for fractures after marginal mandibulectomy for head and neck cancer multicentre study".
Oral Oncol. 2025;170:107716.
PubMed

ZHANG M
Comment on "Uncovering chromatin factor landscapes in head and neck squamous cell carcinoma".
Oral Oncol. 2025;170:107722.
PubMed

HUANG S, Liao D, Zhu X, Feng Y, et al
Advancing oral cancer equity in India novel pathways for screening impact.
Oral Oncol. 2025;170:107696.
PubMed

LI M, Zhou Y, Cai M
Letter to the Editor: Uncovering chromatin factor landscapes in head and neck squamous cell carcinoma.
Oral Oncol. 2025;170:107725.
PubMed

MISRA SR, Das R
Esophageal dysmotility in head and neck cancer survivors: a critical step forward and the path ahead!
Oral Oncol. 2025;170:107718.
PubMed

DUAN Y
Comments on: Stroke risk after head and neck cancer diagnosis and treatment in a real-world clinical cohort.
Oral Oncol. 2025;170:107717.
PubMed

AL MAQRASHI ZAA, Kartolo A, Meyers BM
Resectable locally advanced head and neck squamous cell carcinoma: cut first or immune checkpoint inhibitors first?
Oral Oncol. 2025;170:107704.
PubMed

CHENG H, Jiang M, Kim S, Moshiri A, et al
Uncovering chromatin factor landscapes in head and neck squamous cell carcinoma.
Oral Oncol. 2025;170:107687.
PubMed Abstract available

MISRA SR, Das R
Financial instability, insurance, and transportation barriers in oral cancer care: contrasting perspectives between the United States and India.
Oral Oncol. 2025;169:107692.
PubMed

SAMUEL M
Disparities in oral cancer screening in India: reflections on NFHS 5 evidence and pathways forward.
Oral Oncol. 2025;169:107693.
PubMed Abstract available

SINDYA J, Rajanathadurai J, Perumal E
Reflections on "Low skeletal muscle mass and not systemic inflammation is associated with complications after free forearm flap reconstruction in oral cancer patients".
Oral Oncol. 2025;169:107691.
PubMed

SASIKALA S, Sowmiya A, Usharani N
Letter to the Editor: Salivary DNA methylation derived estimates of biological Aging, cellular frequency and protein expression as predictors of oral mucositis severity and survival in head and neck cancer patients.
Oral Oncol. 2025;169:107668.
PubMed

LUO L, Lu C, Feng H
Refining SCCUP management: towards safe de-escalation in HPV-positive head and neck cancer-letter on Barrett et al.
Oral Oncol. 2025;169:107681.
PubMed

VENKATACHALAM DK, Kanimozhi K
Letter to the Editor "Low skeletal muscle mass and not systemic inflammation is associated with complications after free forearm flap reconstruction in oral cancer patients".
Oral Oncol. 2025;169:107679.
PubMed

MISRA SR, Das R
The imperative of careful selection and novel strategies: Comment on Mrosk et al.'s outcomes of primary chemoradiation for advanced oral cancer.
Oral Oncol. 2025;169:107676.
PubMed

LOVETT JT, Westra WH, Roof S, Bakst RL, et al
Incidence and outcomes of radiation-associated second primary malignancies in HPV-positive oropharyngeal cancer: long-term follow-up of the quarterback de-escalation trials.
Oral Oncol. 2025;169:107654.
PubMed Abstract available

KUMAR GN, Sangeetha S
Comment on "Low skeletal muscle mass and not systemic inflammation is associated with complications after free forearm flap reconstruction in oral cancer patients".
Oral Oncol. 2025 Sep 8:107666. doi: 10.1016/j.oraloncology.2025.107666.
PubMed

XIAO X, Liu T, Song Y, Lu M, et al
Evaluation on the prognostic significance of cervical occult metastasis in cN0 glottic laryngeal cancer.
Oral Oncol. 2025;169:107648.
PubMed

ZHANG D, Zhang J, Cai M
Randomized controlled trial of semi-individualized 3D-printed tissue retraction devices vs. standard shielding splints in head and neck cancer treated with intensity-modulated and particle radiotherapy (GUARD).
Oral Oncol. 2025;169:107660.
PubMed

ZHANG D, Zhang P, Cai M
Letter to the Editor: Randomized controlled trial of semi-individualized 3D-printed tissue retraction devices vs. standard shielding splints in head and neck cancer treated with intensity-modulated and particle radiotherapy (GUARD).
Oral Oncol. 2025;169:107661.
PubMed

DUAN Y
Letter to the Editor: Oral cancer screening in India: A secondary analysis of disparities using national family health survey data.
Oral Oncol. 2025;169:107657.
PubMed

ZHANG D, Zhou Y, Cai M
Letter to the Editor: Randomized controlled trial of semi-individualized 3D-printed tissue retraction devices vs. standard shielding splints in head and neck cancer treated with intensity-modulated and particle radiotherapy (GUARD).
Oral Oncol. 2025;169:107659.
PubMed

MISRA SR, Das R
Critical appraisal of "Oral cancer screening in India: A secondary analysis of disparities using national family health survey data".
Oral Oncol. 2025;169:107653.
PubMed

PENG X, Xie Y, Liu Y
Comment on "Prediction of clinical outcomes of immune checkpoint inhibitors in advanced head and neck cancer directly from histopathology slides using inferred transcriptomics".
Oral Oncol. 2025;169:107644.
PubMed

BATOOL S, Hansen EE, Sethi RKV, Rettig EM, et al
Financial instability, insurance, and transportation influence timely head and neck cancer care in the United States: Patient and healthcare worker perspectives.
Oral Oncol. 2025;169:107607.
PubMed Abstract available

DUNN LA, Ho AL, Michel LS, Wong W, et al
A phase 1/1b study of lenvatinib and cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma.
Oral Oncol. 2025;169:107524.
PubMed Abstract available

NOEL CW, Birkenbeuel J, Ozer E, Agrawal A, et al
Patterns of referral and outcomes in oropharyngeal cancer management.
Oral Oncol. 2025;168:107602.
PubMed Abstract available

GILI R, Morbini P, Bossi P
PD-L1 Expression in head and neck squamous cell carcinoma: qualitative or quantitative assessment? Is that enough or we need something more?
Oral Oncol. 2025;168:107606.
PubMed Abstract available

YANG J, Wu W, Liu J, Li J, et al
Comprehensive integration of single-cell and bulk transcriptome to reveal plasma cell heterogeneity and a prognosis signature in head and neck squamous cell carcinoma.
Oral Oncol. 2025;168:107595.
PubMed Abstract available

KLEEBAYOON A, Wiwanitkit V
Semi-individualized 3D-printed tissue retraction devices vs. standard shielding splints in head and neck cancer treated with intensity-modulated and particle radiotherapy (GUARD): correspondence.
Oral Oncol. 2025;169:107645.
PubMed

BHAGIA P, Mukherjee A, Agarwal T, Giri S, et al
Stroke risk after head and neck cancer diagnosis and treatment in a Real-World clinical cohort: Running title: Treatment in a Real-World clinical cohort.
Oral Oncol. 2025;169:107599.
PubMed Abstract available

August 2025

BARRETT TF, Apicelli AJ, Ramadan S, Pipkorn P, et al
Management of HPV+ head and neck squamous cell carcinoma with unknown primary in the era of treatment de-escalation.
Oral Oncol. 2025;169:107631.
PubMed Abstract available

ANSARI E, Carrillo Minulina N, van Es RJJ, Dieleman FJ, et al
Low skeletal muscle mass and not systemic inflammation is associated with complications after free forearm flap reconstruction in oral cancer patients.
Oral Oncol. 2025;169:107628.
PubMed Abstract available

DAI Y, Li W
Comment on "Randomized controlled trial of semi-individualized 3D-printed tissue retraction devices vs. standard shielding splints in head and neck cancer treated with intensity-modulated and particle radiotherapy (GUARD)" by Schroter et al.
Oral Oncol. 2025;169:107640.
PubMed

KANA L, Chamma B, Robinette N, Cramer JD, et al
Pre-treatment PET/CT for head and neck squamous cell carcinoma: secondary analysis of a clinical trial.
Oral Oncol. 2025;169:107633.
PubMed Abstract available

HUANG J, Yan X, Wang S, Huang S, et al
Improvements to the LEF Self-Management study for head and neck cancer survivors - Letter on Deng et al.
Oral Oncol. 2025;169:107639.
PubMed

CAO J, Han W, Liu Y
Letter to the editor: effects of diagnostic delays in head and neck cancer patients presenting to the emergency department.
Oral Oncol. 2025;169:107624.
PubMed

HUANG X, Gu X
Comment on Lung immune prognostic index is associated with clinical outcomes in recurrent or metastatic (R/M) nasopharyngeal carcinoma receiving immunotherapy: Results from the multicenter, single-arm, phase 2 study.
Oral Oncol. 2025;169:107626.
PubMed

MISRA SR, Das R
Insights on: "Social health at 5 years after diagnosis in head and neck cancer Survivors".
Oral Oncol. 2025;169:107637.
PubMed

BOSSI P, Kiyota N, Mesia R, Rosenberg AJ, et al
Adverse event profiles and management of cisplatin-based chemoradiotherapy in locally advanced head and neck squamous cell carcinoma: a systematic review.
Oral Oncol. 2025;169:107596.
PubMed Abstract available

TANG Y, Jin Q, Gan X
Comment on "Social health at 5 years after diagnosis of head and neck cancer".
Oral Oncol. 2025;169:107627.
PubMed

RAHMAN R, Sheikh I, Merchant Y, Mathur A, et al
Oral cancer screening in India: a secondary analysis of disparities using national family health survey data.
Oral Oncol. 2025;169:107632.
PubMed Abstract available

DAI Y, Li WJ
Comment on "Feasibility and preliminary efficacy of a lymphedema and fibrosis self-management program for head and neck cancer survivors: A pilot randomized controlled trial" by Deng J et al.
Oral Oncol. 2025;169:107613.
PubMed

CHEN Y, Yan Y
Comment on "A preliminary exploration of surgical strategies for solitary papillary thyroid carcinoma on the isthmus".
Oral Oncol. 2025;169:107614.
PubMed

LUO R, Wu J, Zhong W, Ai K, et al
Letter to the editor - Commentary on "A preliminary exploration of surgical strategies for solitary papillary thyroid carcinoma on the isthmus".
Oral Oncol. 2025;169:107610.
PubMed

ZHANG J, Liu DM
Advancing self-management for head and neck cancer-related lymphedema: A promising step forward.
Oral Oncol. 2025;169:107611.
PubMed Abstract available

SCHROTER P, Christ LV, Dvornikovich K, Stritzke F, et al
Randomized controlled trial of semi-individualized 3D-printed tissue retraction devices vs. standard shielding splints in head and neck cancer treated with intensity-modulated and particle radiotherapy (GUARD).
Oral Oncol. 2025;169:107604.
PubMed Abstract available

TANG M, Dougherty M, Worona L, Ramos E, et al
Predictive value of circulating tumor tissue-modified HPV DNA kinetics in induction therapy for oropharyngeal squamous cell carcinoma.
Oral Oncol. 2025;169:107608.
PubMed Abstract available

COLAK G, Demir B
Letter to the Editor: "Effects of diagnostic delays in head and neck cancer patients presenting to the emergency department".
Oral Oncol. 2025;168:107579.
PubMed

TOSONI A, Di Nunno V, Carlini A, Gatto L, et al
The role of systemic therapy in patients with recurrent or metastatic head and neck squamous cell carcinoma progressed to immunotherapy: A systematic review and meta analysis.
Oral Oncol. 2025;168:107582.
PubMed Abstract available

ASHOK A, Dimitri S, Plonowska-Hirschfeld K, Wu MP, et al
Establishing an integrated approach to head and neck cancer treatment and prevention: The Robert Ebert and Greg Stubblefield Head and Neck Tumor Center Model.
Oral Oncol. 2025;168:107591.
PubMed Abstract available

LAVANYA K, Sathishkumar K, Nallusamy D
Letter to the editor: A preliminary exploration of surgical strategies for solitary papillary thyroid carcinoma on the isthmus.
Oral Oncol. 2025;168:107590.
PubMed

HONGO T, Hirano Y, Tarutani Y, Omori H, et al
Prospective study of algorithm-based chemoradioselection to optimize treatment intensity for advanced head and neck cancer.
Oral Oncol. 2025;168:107585.
PubMed Abstract available

KOKER G, Ozcelik G
Comment on: "Cisplatin ototoxicity and hydration schedules''.
Oral Oncol. 2025;168:107545.
PubMed

DENG J, Murphy BA, Andersen LP, McMenamin E, et al
Feasibility and preliminary efficacy of a lymphedema and fibrosis self-management program for head and neck cancer survivors: a pilot randomized controlled trial.
Oral Oncol. 2025;168:107556.
PubMed Abstract available

SUDARSON J
Commentary on "molecular features of T and N stage progression in laryngeal cancer".
Oral Oncol. 2025;168:107587.
PubMed Abstract available

YU Z, Zhuang Z, Zhao X, Chi H, et al
Advancing AI-driven pathology in oral cancer: opportunities for enhanced TIL assessment and clinical integration.
Oral Oncol. 2025;168:107586.
PubMed

ASHOKKUMAR K
Letter to the editor - a preliminary exploration of surgical strategies for solitary papillary thyroid carcinoma on the isthmus.
Oral Oncol. 2025;168:107580.
PubMed

KRISHNAN M, Jothishanmugam A, Mari A, Babu S, et al
Preserving the mandible, protecting the patient: A commentary on fracture risk following marginal mandibulectomy in head and neck cancer.
Oral Oncol. 2025;168:107575.
PubMed

MATSUDA Y, Fujioka-Kobayashi M, Tatsumi H, Osako-Sonoyama R, et al
Factors associated with postoperative oral dysfunction in patients with oral cancer: a structural equation modeling study.
Oral Oncol. 2025;168:107577.
PubMed Abstract available

MULARONI F, Marchi F, Gaudioso P, Taboni S, et al
Selected laryngeal squamous cell carcinomas with laryngeal mobility impairment are suitable for curative larynx-preservation treatment: A multi-institutional study on 406 patients from the ARYFIX collaborative group.
Oral Oncol. 2025;167:107466.
PubMed Abstract available

MORES AL, Lima de Araujo CA, de Freitas Busnardo F, Cardili L, et al
Cutaneous metastasis of oropharyngeal squamous cell carcinoma: A case report.
Oral Oncol. 2025;167:107438.
PubMed Abstract available

SEDASSARI BT, Celin MF, Pigatti FM
SMARCB1-deficient sinonasal carcinoma with oral involvement: A potential mimicker of salivary-type carcinomas.
Oral Oncol. 2025;167:107435.
PubMed Abstract available

TONSBEEK AM, Hundepool CA, van der Oest M, Offerman MPJ, et al
Life following total laryngectomy: mixed-model analyses of longitudinal patient-reported outcomes in a prospective cohort.
Oral Oncol. 2025;167:107431.
PubMed Abstract available

PERYASSU BC, Nicolau-Neto P, da Costa EWE, Santos IC, et al
Assessing the prognostic significance and predictive features of cervical occult metastasis in glottic laryngeal squamous cell carcinoma.
Oral Oncol. 2025;167:107429.
PubMed Abstract available

DOLL C, Hofmann E, Trelinska-Finger A, Heiland M, et al
Benefit from adjuvant radiotherapy in early-stage oral cavity and oropharyngeal cancer with solitary ipsilateral lymph node metastasis - A population-based study on German cancer registry data.
Oral Oncol. 2025;167:107384.
PubMed Abstract available

GUZZO M, Bianchi R, Colombo S, Santamato F, et al
Mandibular swing approach: 25 years of experience at Istituto Nazionale Tumori of Milan.
Oral Oncol. 2025;167:107405.
PubMed Abstract available

TONG JY, Brimanson K, Moyer K, Wolf J, et al
Margin analysis of radical tonsillectomy specimens following transoral robotic surgery.
Oral Oncol. 2025;167:107403.
PubMed Abstract available

LUNA-ORTIZ K, Guillen-Hernandez GA, Cano-Valdez AM, Alvarez-Avitia MA, et al
Poorly differentiated ceruminous adenocarcinoma of the external auditory canal: Letter to the editor.
Oral Oncol. 2025;168:107544.
PubMed

JENNIFER LG, Larnaudie A, Bene MC, Cocherie T, et al
Relationships between oral microbiome and head and neck squamous cell carcinoma: a systematic review.
Oral Oncol. 2025;168:107571.
PubMed Abstract available

HUMBERT M, Perreard M, Licaj I, Bouhnik AD, et al
Social health at 5 years after diagnosis of head and neck cancer.
Oral Oncol. 2025;168:107567.
PubMed Abstract available

July 2025

ELIA A, Tirosh O, Dinstag G, Gugel L, et al
Prediction of clinical outcomes of immune checkpoint inhibitors in advanced head and neck cancer directly from histopathology slides using inferred transcriptomics.
Oral Oncol. 2025;168:107536.
PubMed Abstract available

LI Y, Xiao L, Xie R
Mitigating survival disparities in head and neck cancer: urgent need to reduce ED-based biopsy delays.
Oral Oncol. 2025;168:107549.
PubMed

SHARFUNNISA SH
Letter to the editor "reframing nutritional support in head and neck cancer: insights from a prospective cohort study".
Oral Oncol. 2025;168:107563.
PubMed

ZHANG D, Cai M
Letter to the Editor: A preliminary exploration of surgical strategies for solitary papillary thyroid carcinoma on the isthmus.
Oral Oncol. 2025;168:107558.
PubMed

RAJASEKAR A
Letter to the Editor: HCV infection in head and neck cancer patients: Implications for screening and prognosis in a low prevalence setting.
Oral Oncol. 2025;168:107561.
PubMed Abstract available

HIEROMNIMON HM, Trzcinska A, Wen FT, Howard FM, et al
Corrigendum to "Analysis of AI foundation model features decodes the histopathologic landscape of HPV-positive head and neck squamous cell carcinomas". [Oral Oncol. 163 (2025) 107207].
Oral Oncol. 2025 Jul 27:107510. doi: 10.1016/j.oraloncology.2025.107510.
PubMed

KRISHNAN M, Babu S
Commentary on Lee et al: From crisis to diagnosis: redefining the emergency department's role in head and neck cancer detection.
Oral Oncol. 2025;168:107546.
PubMed

PENG J, Liang Z, Wang J, Wang G, et al
Comment on effects of diagnostic delays in head and neck cancer patients presenting to the emergency department.
Oral Oncol. 2025;168:107537.
PubMed

KRISHNAN M, Babu S
Letter to the editor: redefining surgical paradigms in isthmic papillary thyroid carcinoma: a timely reappraisal.
Oral Oncol. 2025;168:107562.
PubMed

NARENKUMAR J, Parthipan P
Letter to the Editor: Impact of the COVID-19 pandemic on diagnosis and disease stage in HPV-positive oropharyngeal cancer: insights and future directions.
Oral Oncol. 2025;168:107541.
PubMed Abstract available

D'ANDREA C, Marhic A, Leveque E, Thureau S, et al
Risk factors for fractures after marginal mandibulectomy for head and neck cancer multicentre study.
Oral Oncol. 2025;168:107512.
PubMed Abstract available

BABU S, Krishnan M, Ravi PS
"Commentary on: Long-term health-related quality of life in oral cancer survivors following microvascular tongue reconstruction".
Oral Oncol. 2025;168:107552.
PubMed

KRISHNAN M, Chawla KK, Babu S, D S, et al
Letter to the editor: Molecular stratification in papillary thyroid carcinoma: Should RET fusions redefine aggressiveness in the post-BRAF era?
Oral Oncol. 2025;168:107543.
PubMed

MORCOM CR, Williams CMD, Al-Qadami G, Vieyra CP, et al
The biological mechanisms underpinning nutritional and health-related consequences of mucositis in head and neck cancer - A review.
Oral Oncol. 2025;168:107548.
PubMed

ARULMOORTHY MP
Navigating the diagnostic delay: optimizing timely biopsy and integrating NIR-based technologies for head and neck cancer.
Oral Oncol. 2025;168:107518.
PubMed Abstract available

SHARFUNNISA SH, Rahmathullah A
Letter to the editor "Integrating nutritional profiling into immunotherapy: A modifiable predictor of outcomes in head and neck Cancer".
Oral Oncol. 2025;168:107539.
PubMed

BABU S, Solomon A, Krishnan M
Commentary on "Massive nasal bleeding in nasopharyngeal carcinoma: Incidence, risk predictors, and survival impact".
Oral Oncol. 2025;168:107528.
PubMed

JEYARAJ G
Commentary on, "Effects of diagnostic delays in head and neck cancer patients presenting to the emergency department".
Oral Oncol. 2025;168:107532.
PubMed

ABILAJI S, Parthipan P
Letter to the Editor: Evaluating the risk-modifying effects of HSV-1 and HSV-2 on head and neck cancer in relation to tobacco, alcohol, and HPV-16.
Oral Oncol. 2025;168:107516.
PubMed Abstract available

CHAWLA JPS, Madan GK
Comment on "Current status of circulating tumour DNA and circulating cell alterations in HPV-associated head and neck cancer".
Oral Oncol. 2025;168:107526.
PubMed

ZHU J, Xu J, Qu H, Hao J, et al
A preliminary exploration of surgical strategies for solitary papillary thyroid carcinoma on the isthmus.
Oral Oncol. 2025;168:107511.
PubMed Abstract available

LEE MY, Huynh JD, Kim DD, Sunwoo JB, et al
Effects of diagnostic delays in head and neck cancer patients presenting to the emergency department.
Oral Oncol. 2025;168:107467.
PubMed Abstract available

YANG Z, Lin B, Xie R
Microvascular tongue reconstruction in oral cancer: Long-term functional outcomes and quality of life considerations.
Oral Oncol. 2025;167:107490.
PubMed

ZHANG Y, Liang R, Lai P
Comment on "The association between health-related quality of life and five-year overall survival among head and neck cancer patients: A prospective cohort study".
Oral Oncol. 2025;167:107491.
PubMed

JEYARAJ G
Commentary on, "Transoral endoscopic thyroidectomy vestibular approach for pT1b papillary thyroid carcinoma: Surgical and oncological outcomes.".
Oral Oncol. 2025;167:107487.
PubMed

RAJATHIRAJAN SD
Commentary on, "Impact of HIV status on overall survival in head and neck cancers by anatomical site and stage: A multi-center cohort study".
Oral Oncol. 2025;167:107483.
PubMed

JEYARAJ G
Commentary on, "Massive nasal bleeding in nasopharyngeal Carcinoma: Incidence, risk Predictors, and survival impact.".
Oral Oncol. 2025;167:107488.
PubMed

CHENG HS, Lin TY, Twu CW, Lin PJ, et al
Corrigendum to "Massive nasal bleeding in nasopharyngeal carcinoma: incidence, risk predictors, and survival impact" [Oral Oncol. 167 (2025) 107456].
Oral Oncol. 2025 Jul 4:107465. doi: 10.1016/j.oraloncology.2025.107465.
PubMed

RAJATHIRAJAN SD
Commentary on, "Computed tomography radiomics-based cross-sectional detection of mandibular osteoradionecrosis in head and neck cancer survivors".
Oral Oncol. 2025;167:107472.
PubMed

HU A, Wen X, Tian J, Wang Z, et al
RET fusion rather than BRAF mutation confers a higher risk of aggressiveness and recurrence in papillary thyroid carcinoma.
Oral Oncol. 2025;167:107464.
PubMed Abstract available

RIJKEN JA, de Ridder M, Devriese LA, Breimer GE, et al
Long-term survival after multimodal treatment of sinonasal NUT carcinoma: a case report.
Oral Oncol. 2025;166:107392.
PubMed Abstract available

RONDI P, Mattavelli D, Rampinelli V, Schreiber A, et al
The role of volumetry in sinonasal cancer response assessment to induction chemotherapy, results from two phase II non-randomized controlled prospective multicentric trials: SINTART-1 and SINTART-2.
Oral Oncol. 2025;166:107388.
PubMed Abstract available

SOMAY E, Bascil S, Topkan E, Selek U, et al
Re: "Computed tomography radiomics-based cross-sectional detection of mandibular osteoradionecrosis in head and neck cancer survivors" by Kamel et al.
Oral Oncol. 2025;167:107457.
PubMed

June 2025

MALGAVE DS, Hartman CM, Kramer JR, Richardson PA, et al
Impact of HIV status on overall survival in head and neck cancers by anatomical site and stage: A multi-center cohort study.
Oral Oncol. 2025;167:107446.
PubMed Abstract available

ABILAJI S, Narenkumar J
Letter to the Editor: Enhancing early detection of HPV associated oropharyngeal cancer: a comparative study of NGS, ddPCR, and qPCR.
Oral Oncol. 2025 Jun 27:107461. doi: 10.1016/j.oraloncology.2025.107461.
PubMed Abstract available

EICKELSCHULTE S, Starus A, Murray DH, Keyser KA, et al
Analytical and clinical performance validation of HPV-SEQ, a novel NGS-based liquid biopsy platform for detection and quantification of human papilloma virus circulating tumor DNA.
Oral Oncol. 2025;167:107445.
PubMed Abstract available

RAJATHIRAJAN SD
Commentary on, "Optimal induction chemotherapy courses in nasopharyngeal carcinoma in the IMRT era: A recursive partitioning risk stratification analysis based on EBV DNA and AJCC staging".
Oral Oncol. 2025;167:107453.
PubMed

CHENG HS, Lin TY, Twu CW, Lin PJ, et al
Massive nasal bleeding in nasopharyngeal Carcinoma: Incidence, risk Predictors, and survival impact: Running title: Massive nasal bleeding in NPC.
Oral Oncol. 2025;167:107456.
PubMed Abstract available

DAUNGSUPAWONG H, Wiwanitkit V
Optimal induction chemotherapy courses in nasopharyngeal carcinoma in the IMRT era: Comment.
Oral Oncol. 2025;167:107454.
PubMed

SAMUEL CHAN SW, Amer Al Maqrashi ZA, Kim DH, Choi D, et al
Induction chemotherapy and immunotherapy followed by chemo-radiotherapy in incurable advanced head and neck squamous cell carcinoma: A case-series.
Oral Oncol. 2025;167:107439.
PubMed

NGO DQ, Truong DS, Le DT, Hoang TM, et al
Transoral endoscopic thyroidectomy vestibular approach for pT1b papillary thyroid carcinoma: surgical and oncological outcomes.
Oral Oncol. 2025;167:107406.
PubMed Abstract available

ARAUJO M, Bouassaly J, Farshadi F, Hier M, et al
Current status of circulating tumor DNA and circulating cell alterations in HPV-associated head and neck cancer.
Oral Oncol. 2025;167:107417.
PubMed Abstract available

KAMEL S, Humbert-Vidan L, Kaffey Z, Mirbahaeddin S, et al
Computed tomography radiomics-based cross-sectional detection of mandibular osteoradionecrosis in head and neck cancer survivors.
Oral Oncol. 2025;167:107337.
PubMed Abstract available

MAK CH, Cao LM, Luo HY, Zhou K, et al
Postoperative complications of neck dissection for head and neck squamous cell carcinoma: a systematic review and meta-analysis.
Oral Oncol. 2025;167:107430.
PubMed Abstract available

YANG X, Li R
Reconsidering the prognostic value of HRQOL in head and neck cancer.
Oral Oncol. 2025;167:107421.
PubMed

YAN Y, Wang Z, Sun Y
Comment on: Margins do not impact recurrence and survival in advanced laryngeal cancer-A retrospective cohort analysis.
Oral Oncol. 2025;167:107427.
PubMed

LIANG YJ, Luo MJ, Wen DX, Wang P, et al
Optimal induction chemotherapy courses in nasopharyngeal carcinoma in the IMRT era: A recursive partitioning risk stratification analysis based on EBV DNA and AJCC staging.
Oral Oncol. 2025;167:107404.
PubMed Abstract available

KIM MJ, Koo BS, Cho KJ, Lee SH, et al
Health-related quality-of-life assessment in patients with oropharyngeal cancer: A comparison of EQ-5D-5L and EORTC instruments.
Oral Oncol. 2025;165:107342.
PubMed Abstract available

GARSET-ZAMANI M, Makouei F, Agander TK, Lelkaitis G, et al
Feasibility of 3D ultrasound for intraoperative tumor margin assessment in transoral robotic surgery for oropharyngeal squamous cell carcinoma: A pilot study.
Oral Oncol. 2025;165:107330.
PubMed Abstract available

KUMARI S, Mishra S, Ali W, Singh US, et al
Implication of circulating miRNAs as potential diagnostic biomarker in oropharyngeal squamous cell Carcinoma: Association with Human Papilloma Virus.
Oral Oncol. 2025;165:107305.
PubMed Abstract available

JANG HB, Lee DH, Lim SC
Treatment outcomes of sinonasal adenoid cystic carcinoma: a single-center experience.
Oral Oncol. 2025;165:107317.
PubMed Abstract available

CHELVARAJAH RC, Liu Y, Su J, Abdalaty AH, et al
Factors associated with detection of oligometastatic recurrence and outcome following definitive (Chemo)radiotherapy for oropharyngeal carcinoma.
Oral Oncol. 2025;165:107310.
PubMed Abstract available

May 2025

HINTZE JM, Cleere E, Soo A, Timon C, et al
Margins do not impact recurrence and survival in advanced laryngeal cancer - A retrospective cohort analysis.
Oral Oncol. 2025;167:107402.
PubMed Abstract available

BAIJU DC, Ravi J, Sarma M, Sureshan M, et al
Detection of hotspot mutations in oral cancer through Ion AmpliSeq cancer hotspot panel v.2.0: A circulating DNA fragmentomics approach in the Northeast Indian population.
Oral Oncol. 2025;166:107387.
PubMed Abstract available

JEYARAJ G
Commentary on, "The association between health-related quality of life and five-year overall survival among head and neck cancer patients: A prospective cohort study".
Oral Oncol. 2025;166:107401.
PubMed

LIU X, Xue S
Comment on: Risk factors of lymph node metastasis in the diffuse sclerosing variant of papillary thyroid carcinoma compared with conventional papillary thyroidcarcinoma in pediatric populations.
Oral Oncol. 2025;166:107368.
PubMed

VERDONCK-DE LEEUW IM, Lissenberg-Witte BI, de Bree R, Buffart LM, et al
The association between health-related quality of life and five-year overall survival among head and neck cancer patients: A prospective cohort study.
Oral Oncol. 2025;166:107367.
PubMed Abstract available

OLSON B, Bogan A, Abdel-Halim CN, Rolle-McFarland D, et al
Identification of clinical and pathologic features associated with extranodal extension in patients with HPV-mediated oropharyngeal squamous cell carcinoma.
Oral Oncol. 2025;166:107308.
PubMed Abstract available

TONSBEEK AM, van der Lely JN, Bulstra L, Venema J, et al
Long-term health-related quality of life in oral cancer survivors following microvascular tongue reconstruction.
Oral Oncol. 2025;166:107363.
PubMed Abstract available

MALI SB
Corrigendum to "Review of STAT3 (Signal Transducers and Activators of Transcription) in head and neck cancer" [Oral Oncol. 51 (2015) 565-569].
Oral Oncol. 2025 May 10:107357. doi: 10.1016/j.oraloncology.2025.107357.
PubMed

MALI SB
Corrigendum to "RNA interference in oral cancer" [Oral Oncol. 51 (2015) e2-e3].
Oral Oncol. 2025 May 9:107358. doi: 10.1016/j.oraloncology.2025.107358.
PubMed

SHAIKH N, Pandey M, Manna S, Gawde J, et al
Evaluating the prognostic value of tumor-derived circulating endothelial cells and their progenitors in platinum-refractory oral cancer patients for response to triple metronomic therapy.
Oral Oncol. 2025;165:107346.
PubMed Abstract available

COSTANTINO A, Haughey BH, Alamoudi U, Magnuson JS, et al
Prognostic significance of distant metastasis site at diagnosis in HPV-related oropharyngeal cancer.
Oral Oncol. 2025;165:107361.
PubMed Abstract available

ONAGA R, Enokida T, Kuno H, Hiyama T, et al
Significance of imaging-detected extranodal extension in locally advanced squamous cell carcinoma of the head and neck treated with induction chemotherapy followed by chemoradiotherapy.
Oral Oncol. 2025;165:107351.
PubMed Abstract available

ZHU X, Xu H, Zhao Y, Diao W, et al
Single-cell transcriptomics reveal the effects of chemoimmunotherapy on hypopharyngeal cancer and its tumor microenvironment.
Oral Oncol. 2025;165:107347.
PubMed Abstract available

PEI Y, Yang Z, Mao Y, Chen X, et al
Evolving dynamics in clinical trials for oral cancer: Trends, treatment modalities, and future directions.
Oral Oncol. 2025;165:107333.
PubMed Abstract available

XIAO X, Liu T, Lu M, Song Z, et al
Comment on the role of lymph node level ratio in predicting prognosis of pN1 head and neck squamous cell carcinoma.
Oral Oncol. 2025;165:107344.
PubMed

CHENNAREDDY S, Chen S, Levinson C, Genden EM, et al
Circulating tumor DNA in human papillomavirus-associated oropharyngeal cancer management: A systematic review.
Oral Oncol. 2025;164:107262.
PubMed Abstract available

MARCHI F, Del Bon F, Chu F, Sampieri C, et al
Refining prognostic subcategories in intermediate-advanced glottic cancer: A multicentric study on 637 patients treated by transoral laser microsurgery.
Oral Oncol. 2025;164:107264.
PubMed Abstract available

CANALI L, Russo E, Pangallo S, Bussu F, et al
Regional disease control in nasal vestibule squamous cell carcinoma: Systematic review and meta-analysis.
Oral Oncol. 2025;164:107270.
PubMed Abstract available

MOTTA G, Magno C, Castagna L, De Berardinis T, et al
Endoscope-assisted trans-oral approach (EATA) to remove a rare pleomorphic adenoma of the nasopharynx.
Oral Oncol. 2025;164:107260.
PubMed Abstract available

BEDDOK A, Popovtzer A, Calugaru V, Fontaine M, et al
Proton therapy for primary and recurrent HPV-related oropharyngeal cancer.
Oral Oncol. 2025;165:107309.
PubMed Abstract available

April 2025

MALI SB
Corrigendum to "Proteomics for oral cancer" [Oral Oncol. 50(11) (2014) e67].
Oral Oncol. 2025 Apr 30:107338. doi: 10.1016/j.oraloncology.2025.107338.
PubMed

CITRO S, Ghiani L, Doni M, Miccolo C, et al
HPV-mediated PARP1 regulation and drug sensitization in head and neck cancer.
Oral Oncol. 2025;165:107307.
PubMed Abstract available

SILVA CUNHA JL
Comment on "Histological tumor necrosis predicts decreased survival after neoadjuvant chemotherapy in head and neck squamous cell carcinoma".
Oral Oncol. 2025;165:107336.
PubMed

AL FADEL AM, Jakobsen KK, Jensen LH, Carlander AF, et al
The epidemiological trends and survival of HPV-related oropharyngeal cancer other than tonsils and base of tongue - a systematic review and meta-analysis.
Oral Oncol. 2025;165:107311.
PubMed Abstract available

ARDILA CM
Enhancing the scope and impact of photobiomodulation research in head and neck cancer therapy.
Oral Oncol. 2025;165:107303.
PubMed

JEYARAJ G
Commentary on, "Molecular features of T and N stage progression in laryngeal cancer.".
Oral Oncol. 2025;165:107331.
PubMed

BARCELONA MVN, Waldron J, Sullivan BO, Su J, et al
Outcomes following IMRT alone in head and neck squamous cell carcinoma ordinarily managed with concurrent chemo-radiotherapy.
Oral Oncol. 2025;165:107299.
PubMed Abstract available

YAO CMKL, Hueniken K, Huang SH, Liu G, et al
Development of a patient reported outcomes based machine learning model to predict recurrences in head and neck cancer.
Oral Oncol. 2025;165:107304.
PubMed Abstract available

JEYARA G
Commentary on, "Risk factors and a risk assessment model for venous thromboembolism in head and neck cancer surgery.".
Oral Oncol. 2025;165:107320.
PubMed

ZHOU P, Zhu Y, Xu B, Jiang X, et al
Cavernous sinus syndrome in a patient with occult nasopharyngeal carcinoma: A diagnostic challenge.
Oral Oncol. 2025;165:107316.
PubMed Abstract available

COSTANTINO A, Sampieri C, Haughey BH, Alamoudi U, et al
Adjuvant treatment in elderly patients undergoing transoral surgery for HPV-related oropharyngeal cancer.
Oral Oncol. 2025;165:107312.
PubMed Abstract available

KOSKENNIEMI AR, Huusko T, Routila J, Jalkanen S, et al
Histological tumor necrosis predicts decreased survival after neoadjuvant chemotherapy in head and neck squamous cell carcinoma.
Oral Oncol. 2025;165:107287.
PubMed Abstract available

JEYARAJ G
Commentary on, "Effect of Enhanced Recovery After Radiotherapy (ERAR) on the quality of life in patients with nasopharyngeal carcinoma after radiotherapy: A randomized controlled trial".
Oral Oncol. 2025;165:107302.
PubMed

LI N, Zeng PYF, Kim HAJ, Karimi A, et al
Molecular features of T and N stage progression in laryngeal cancer.
Oral Oncol. 2025;165:107283.
PubMed Abstract available

BURGER AVM, Koot MA, van Balen DEM, Schaeffers AWMA, et al
Comparison of cisplatin-induced hearing loss in different durations of infusion and volume of hydration schedules in head and neck squamous cell carcinoma patients treated with cisplatin-based chemoradiation.
Oral Oncol. 2025;164:107246.
PubMed Abstract available

HANNA GJ, Zheng D, Gao W, Hair GM, et al
Corrigendum to "PD-L1 testing patterns in recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) in the U.S." [Oral Oncol. 161 (2025) 107146].
Oral Oncol. 2025 Apr 11:107292. doi: 10.1016/j.oraloncology.2025.107292.
PubMed

MA J, Brooks C, Tasoulas J, Wind LS, et al
Revisiting the use of capecitabine in the era of immunotherapy: Efficacy as second-line and later therapy in recurrent/metastatic head and neck squamous cell carcinoma.
Oral Oncol. 2025;164:107293.
PubMed

SLATER NN, Herberger L, Farsi S, Rogers AL, et al
Assessing barriers to adjuvant therapy among patients with head and neck cancer in Arkansas.
Oral Oncol. 2025;164:107290.
PubMed Abstract available

XIAO J, You M, Song Y, Gao R, et al
Risk factors and a risk assessment model for venous thromboembolism in head and neck cancer surgery.
Oral Oncol. 2025;164:107288.
PubMed Abstract available

VIANNA CAMOLESI GC, Prado-Pena IB, Gomez-Caamano A, Victoria-Fernandez C, et al
Photobiomodulation for the prevention of oral side effects secondary to head and neck cancer therapy: results of a randomised, single-blind clinical trial.
Oral Oncol. 2025;164:107266.
PubMed Abstract available

JEYARAJ G
Commentary on, "Evaluation of a comprehensive set of normal tissue complication probability models for patients with head and neck cancer in an international cohort".
Oral Oncol. 2025;164:107285.
PubMed

ROSING F, Plath M, Proctor T, Hofler D, et al
Post-treatment monitoring of surgically treated oropharyngeal squamous cell carcinoma patients using human papillomavirus cell-free DNA.
Oral Oncol. 2025;163:107225.
PubMed Abstract available

March 2025

LIN N, Zhou X, Wang Y, Zhou J, et al
Effect of enhanced recovery after radiotherapy (ERAR) on the quality of life in patients with nasopharyngeal carcinoma after radiotherapy: A randomized controlled trial.
Oral Oncol. 2025;164:107269.
PubMed Abstract available

JEYARAJ G
Commentary on, "Thyroid volumes after intensity-modulated radiotherapy as predictors of radiation-induced hypothyroidism in nasopharyngeal carcinoma: A retrospective study".
Oral Oncol. 2025;163:107256.
PubMed

ARDILA CM, Yadalam PK
AI-driven histopathologic insights in HPV-positive head and neck squamous cell carcinomas.
Oral Oncol. 2025;163:107261.
PubMed

MATHEW JM, Busca I, Baskurt Z, Giuliani M, et al
Changes in unmet needs after treatment for head and neck cancers - A prospective longitudinal cohort study.
Oral Oncol. 2025;163:107250.
PubMed Abstract available

DONG Z, Wang GY, Qin GJ, Dai DY, et al
Thyroid volumes after intensity-modulated radiotherapy as predictors of radiation-induced hypothyroidism in nasopharyngeal carcinoma: A retrospective study.
Oral Oncol. 2025;163:107223.
PubMed Abstract available

LORENZ FJ, Kharouta M, Mahase SS, Goyal N, et al
Hospital-Based Registry Analysis of Staging Efficacy and Proposed Staging Subclassification for Stage I HPV-Associated Oropharyngeal Squamous Cell Carcinoma.
Oral Oncol. 2025;163:107251.
PubMed Abstract available

PETRELLI F, Lorini L, Paderno A, Carioli D, et al
Treatment of primary tumor in metastatic head and neck Carcinoma: A systematic review and Meta-Analysis.
Oral Oncol. 2025;163:107248.
PubMed Abstract available

HIEROMNIMON HM, Trzcinska A, Wen FT, Howard FM, et al
Analysis of AI foundation model features decodes the histopathologic landscape of HPV-positive head and neck squamous cell carcinomas.
Oral Oncol. 2025;163:107207.
PubMed Abstract available

GAZZINI L, Festa BM, Calabrese L
Elective neck dissection: Are we bound to outdated concepts?
Oral Oncol. 2025;163:107245.
PubMed

WU WJ, An PG, Liu Q, Zhang ZQ, et al
Neoadjuvant chemoimmunotherapy brings superior quality of life of patients with locally advanced oral or oropharyngeal cancer: A propensity score-matched analysis.
Oral Oncol. 2025;162:107218.
PubMed Abstract available

YANG F, Peng W, Wei H, Li X, et al
Model-free parameters derived from intravoxel inherent motion combined with tumor aggressiveness indicators in predicting 5-year treatment outcome in NPC.
Oral Oncol. 2025;162:107187.
PubMed Abstract available

YE Z, Li X, Xie F, Sun J, et al
A single-cell sequencing-based analysis of a 13-year-old with maxillary sinus NUT carcinoma.
Oral Oncol. 2025;162:107185.
PubMed Abstract available

CHARLTON A, Mughal Z, Sharin F, Sahota RB, et al
Prevalence of synchronous bilateral/contralateral tonsil carcinoma: A systematic review and meta-analysis.
Oral Oncol. 2025;162:107180.
PubMed Abstract available

DE VETTE SPM, van Rijn-Dekker MI, Van den Bosch L, Keijzer K, et al
Evaluation of a comprehensive set of normal tissue complication probability models for patients with head and neck cancer in an international cohort.
Oral Oncol. 2025;163:107224.
PubMed Abstract available

MIYAGUCHI J, Shiga K, Katagiri K, Saito D, et al
Efficacy of boron neutron capture therapy (BNCT) for patients with oral cancer.
Oral Oncol. 2025;163:107228.
PubMed Abstract available

February 2025

WICZUK-WICZEWSKA M, Bernaciak J, Nogal P, Bugaj A, et al
Squamous cell carcinoma in the posterior larynx: A rare localization of supraglottic T1 laryngeal cancer. Case report.
Oral Oncol. 2025;163:107227.
PubMed Abstract available

JEYARAJ G
Letter to the editor, "Mitoxantrone hydrochloride liposome injection for the treatment of Recurrent/Metastatic head and neck squamous cell carcinoma: A multicenter, open-label, single-arm, phase 1b study.".
Oral Oncol. 2025;163:107231.
PubMed

TINO RB, Roach MA, Fuentes GD, Agrawal A, et al
Response to recent comments on "Development and clinical implementation of a digital workflow utilizing 3D-printed oral stents for patients with head and neck cancer receiving radiotherapy".
Oral Oncol. 2025;162:107220.
PubMed

MEEKER BS MO, Katragadda A, Alsavaf MB, Birkenbeuel J, et al
Dysphagia in head and neck cancer patients with evidence of esophageal dysmotility on manometry.
Oral Oncol. 2025;162:107219.
PubMed Abstract available

YANG H, Sun P, Wang Y, Wang X, et al
Mitoxantrone hydrochloride liposome injection for the treatment of Recurrent/Metastatic head and neck squamous cell Carcinoma: A Multicenter, Open-label, Single-arm, phase 1b study.
Oral Oncol. 2025;162:107211.
PubMed Abstract available

IQBAL MS, West N, Kovarik J, Jackson M, et al
Effective, efficient palliative radiotherapy for advanced head and neck cancer: Real world data using 25 Gy in 5 fractions.
Oral Oncol. 2025;162:107214.
PubMed

KHAN A, Pillay M, Bipath R, Msimang M, et al
Evolution of testing for the diagnosis of human papillomavirus (HPV) status in head and neck squamous cell carcinoma: Where from and where to?
Oral Oncol. 2025;162:107208.
PubMed Abstract available

MO Y, Wei Y, Liang L, Wu T, et al
Clinical significance of post-chemoradiotherapy 2-[(18)F]FDG PET/CT response in locally advanced nasopharyngeal carcinoma: A real-world study.
Oral Oncol. 2025;161:107160.
PubMed Abstract available

LOUBIERES C, Baudouin R, Circiu M, Couineau F, et al
Functional and oncological outcomes of transoral laser versus robotic surgery in supraglottic squamous cell carcinoma.
Oral Oncol. 2025;161:107178.
PubMed Abstract available

PERSHAD AR, Ferraro T, Shaver TB, Lee E, et al
Pathologic responses and clinical outcomes with neoadjuvant doublet chemotherapy for newly diagnosed, surgically-resectable p16-positive oropharyngeal cancer.
Oral Oncol. 2025;161:107139.
PubMed Abstract available

FENG ZK, Wu WB, Zou RC, Zhang JZ, et al
Postradiotherapy nasopharyngeal necrosis with granulation mass: Insights from a multicentre study.
Oral Oncol. 2025;161:107170.
PubMed Abstract available

LYU SI, Fretter C, Eckel HNC, Knipper K, et al
High expression of H2AX/gamma-H2AX is associated with distinct biological pathway alterations and shorter survival in oropharyngeal squamous cell carcinoma.
Oral Oncol. 2025;161:107171.
PubMed Abstract available

KWON JJ, Milner TD, Kurten C, Pang EH, et al
Towards transcervical ultrasound-guided transoral robotic surgery.
Oral Oncol. 2025;161:107167.
PubMed Abstract available

SUCHAN M, Wuerdemann N, Wagner S, Langer C, et al
Histological and genetic criteria define a clinically relevant subgroup of HPV-positive oropharyngeal carcinoma.
Oral Oncol. 2025;162:107209.
PubMed Abstract available

January 2025

WENGER TA, Gao J, Nurimba M, Phung PG, et al
Palliative care utilization among head and neck cancer patients: A population-based analysis.
Oral Oncol. 2025;162:107205.
PubMed Abstract available

CHEN L, Fang R, Cai Z, Huang B, et al
CD271(high) cancer stem cells regulate macrophage polarization in head and neck squamous cell carcinoma.
Oral Oncol. 2025;162:107181.
PubMed Abstract available

YIN Z, Zhao H, Zhu C, Fang J, et al
Comment on: Development and clinical implementation of a digital workflow utilizing 3D-printed oral stents for patients with head and neck cancer receiving radiotherapy.
Oral Oncol. 2025;161:107195.
PubMed

JIANG H, Zhou L, Zhao T, Zou G, et al
Anaplastic thyroid carcinoma in a 43-year-old female confirmed by metastatic lymph node pathology: A case report.
Oral Oncol. 2025;161:107192.
PubMed

JIANG H, Zhou L, Zou G, Zhang H, et al
Synchronous papillary and medullary thyroid carcinoma with distinct genetic mutations: A case report.
Oral Oncol. 2025;161:107191.
PubMed

LI MH, Hu YJ, Shan HM, Gao XL, et al
The role of lymph node level ratio in predicting prognosis and the benefits of postoperative radiotherapy in patients with pathological N1 stage head and neck squamous cell carcinoma.
Oral Oncol. 2025;161:107193.
PubMed Abstract available

HUTTINGER ZM, Gogineni E, Baliga S, Blakaj DM, et al
Circulating tumor DNA determines induction chemotherapy response in HPV associated oropharyngeal squamous cell carcinoma: A pilot study.
Oral Oncol. 2025;161:107179.
PubMed Abstract available

TOPKAN E, Somay E, Selek U
Commentary on "Induction chemotherapy for locally advanced nasopharyngeal carcinoma: Efficacy and safety of the TPC regimen compared to GP and TPF".
Oral Oncol. 2025;161:107175.
PubMed

SENYUREK S, Durankus NK, Selek U, Topkan E, et al
Comment on "The effect of time from surgery to commencing adjuvant radiotherapy for patients with head and neck squamous cell carcinoma".
Oral Oncol. 2025;161:107177.
PubMed

GIUNCO S, Del Mistro A, Morello M, Lidonnici J, et al
From infection to immortality: The role of HPV and telomerase in head and neck cancer.
Oral Oncol. 2025;161:107169.
PubMed Abstract available

HANNA GJ, Zheng D, Gao W, Hair GM, et al
PD-L1 testing patterns in recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) in the U.S.
Oral Oncol. 2025;161:107146.
PubMed Abstract available

XU S, He J, Liu Z, Pei Y, et al
Immune-related adverse events as prognostic biomarkers in recurrent or metastatic nasopharyngeal carcinoma receiving PD-L1 inhibitor: A post-hoc analysis of the multicenter, single-arm, phase 2 study.
Oral Oncol. 2025;161:107161.
PubMed Abstract available

December 2024

KAOREY N, Dickinson K, Agnihotram VR, Zeitouni A, et al
The role of ctDNA from liquid biopsy in predicting survival outcomes in HPV-negative head and neck cancer: A meta-analysis.
Oral Oncol. 2024;161:107148.
PubMed Abstract available

LIU Y, Fu N, Liu H, Su S, et al
Corrigendum to "Risk factors of lymph node metastasis in the diffuse sclerosing variant of papillary thyroid carcinoma compared with conventional papillary thyroidcarcinoma in pediatric populations" [160 (2025) 107120/Article:OO_107120].
Oral Oncol. 2024 Dec 30:107135. doi: 10.1016/j.oraloncology.2024.107135.
PubMed

DIETRICH N, Watson E, Tadic T, Martino R, et al
Development of a prediction model for tube feeding dependence in HPV-associated oropharyngeal cancer patients undergoing chemoradiotherapy.
Oral Oncol. 2024;161:107132.
PubMed Abstract available

FANG Q, Yuan J, Zhang X, Dai L, et al
Omitting elective neck dissection in cT1/2N0 oral squamous cell carcinoma with sentinel lymph node metastasis: A prospective study.
Oral Oncol. 2024;161:107149.
PubMed Abstract available

PRICE JM, Garcez K, Hughes C, Lee LW, et al
The effect of time from surgery to commencing adjuvant radiotherapy for patients with head and neck squamous cell carcinoma.
Oral Oncol. 2024;161:107138.
PubMed Abstract available

STRUCKMEIER AK, Gosau M, Smeets R
Immunotherapeutic strategies beyond the PD-1/PD-L1 pathway in head and neck squamous cell carcinoma - A scoping review on current developments in agents targeting TIM-3, TIGIT, LAG-3, and VISTA.
Oral Oncol. 2024;161:107145.
PubMed Abstract available

MEGWALU UC, Ma Y, Divi V
Association of race and ethnicity with quality of care among head and neck cancer patients in California.
Oral Oncol. 2024;161:107144.
PubMed Abstract available

PACE GM, Costantino A, De Virgilio A
Comment on "Surgical, functional, and oncological outcomes of transoral robotic surgery for cT1-T3 supraglottic laryngeal cancers: A systematic review".
Oral Oncol. 2024;161:107142.
PubMed

YU ST, Huang D, Xiong C, Xie R, et al
Selperctinib as neoadjuvant therapy for RET-altered papillary thyroid carcinoma: Two case reports.
Oral Oncol. 2024;161:107140.
PubMed Abstract available

ALMEIDA ND, Yu H, Iovoli AJ, Fang M, et al
Prophylactic gastrostomy tube during chemoradiation for head and neck cancer decreases weight loss but increases rate of tube use beyond six months.
Oral Oncol. 2024;160:107136.
PubMed Abstract available

DA MOTA SANTANA LA, Dos Santos Barreto M, Santos GA, Gopalsamy RG, et al
Comment on "Time to treatment for head and neck cancer patients decreased during the early phase of the COVID-19 pandemic".
Oral Oncol. 2024;160:107134.
PubMed

PRACHA SH, Shrestha S, Ryan N, Upadhaya P, et al
Targeting macrophage migration inhibitory factor to inhibit T cell immunosuppression in the tumor microenvironment and improve cancer outcomes in head and neck squamous cell carcinoma.
Oral Oncol. 2024;160:107126.
PubMed Abstract available

LI H, Lou L, Du J, Li M, et al
Multimodal profiling uncovers tertiary lymphoid structures as a critical determinant of immunotherapy response and prognosis in nasopharyngeal carcinoma.
Oral Oncol. 2024;160:107129.
PubMed Abstract available

SANKAR GANESH P, Naseef Pathoor N, Kanna Gopal R
Letter to the editor regarding, "Impact of post-operative transoral robotic surgery hemorrhage on adjuvant treatment delays in patients with oropharyngeal squamous cell carcinoma".
Oral Oncol. 2024;159:107091.
PubMed Abstract available

BALAJI H, Aithal VU, Varghese JJ, Devaraja K, et al
Agreement between patient-reported and clinician-rated speech and swallowing outcomes - Understanding the trend in post-operative oral cavity cancer patients.
Oral Oncol. 2024;159:107068.
PubMed Abstract available

BALAGURU L, Hanubal KS, Galochkina Z, Lee JH, et al
Surgical and functional outcomes after salvage oropharyngectomy.
Oral Oncol. 2024;159:107050.
PubMed Abstract available

KORIC A, Chang CP, Hu S, Snyder J, et al
Oral health-related quality of life among oropharyngeal cancer survivors.
Oral Oncol. 2024;159:107062.
PubMed Abstract available

BOZKURT G, Turri Zanoni M, Ferrari M, Ioppi A, et al
Salvage surgery in nasopharyngeal Cancer: Unraveling the efficacy of transnasal endoscopic nasopharyngectomy for advanced stage recurrent tumors.
Oral Oncol. 2024;159:107048.
PubMed Abstract available

DANIELS KE, Awad DR, Liu SX, Mocharnuk J, et al
Impact of post-operative transoral robotic surgery hemorrhage on adjuvant treatment delays in patients with oropharyngeal squamous cell carcinoma.
Oral Oncol. 2024;159:107031.
PubMed Abstract available

GREEN L, McDowell L, Ip F, Tapia M, et al
Early return to work is possible after transoral robotic surgery (TORS) in carefully selected patients with oropharyngeal squamous cell carcinoma.
Oral Oncol. 2024;159:107032.
PubMed Abstract available

LU YT, Lin CW, Su SC, Ho YT, et al
L48H37, a curcumin analog, suppresses matrix metalloproteinase-9 expression and activity to hamper nasopharyngeal cancer cell migration.
Oral Oncol. 2024;159:107038.
PubMed Abstract available

STAIBANO P, Au M, Xie M, Gupta MK, et al
Return to work and self-reported swallowing following transoral robotic surgery for early-stage oropharyngeal squamous cell carcinoma: A retrospective cohort study.
Oral Oncol. 2024;159:107033.
PubMed Abstract available

MORTAJA S, Chiumenti FA, Kalaskar DM, Dwivedi RC, et al
Surgical complications and functional outcomes of 3191 jejunal free flaps used for reconstruction of circumferential defects following head and neck cancer resections: A systematic review.
Oral Oncol. 2024;160:107130.
PubMed Abstract available

November 2024

MARRET G, Lamy C, Vacher S, Cabel L, et al
Deciphering molecular relapse and intra-tumor heterogeneity in non-metastatic resectable head and neck squamous cell carcinoma using circulating tumor DNA.
Oral Oncol. 2024;160:107111.
PubMed Abstract available

JEYARAJ G
Letter to the editor, "Loss of MACROD2 drives radioresistance but not cisplatin resistance in HPV-positive head and neck cancer.".
Oral Oncol. 2024;160:107092.
PubMed

LIU Y, Fu N, Liu H, Su S, et al
Risk factors of lymph node metastasis in the diffuse sclerosing variant of papillary thyroid carcinoma compared with conventional papillary thyroidcarcinoma in pediatric populations.
Oral Oncol. 2024;160:107120.
PubMed Abstract available

YAN C, Wang R, Zhang C, Lin G, et al
Induction chemotherapy for locally advanced nasopharyngeal carcinoma: Efficacy and safety of the TPC regimen compared to GP and TPF.
Oral Oncol. 2024;160:107119.
PubMed Abstract available

VON WITZLEBEN A, Grages A, Thomas J, Ezic J, et al
Immune checkpoint expression on tumor-infiltrating lymphocytes (TIL) is dependent on HPV status in oropharyngeal carcinoma (OPSCC) - A single-cell RNA sequencing analysis.
Oral Oncol. 2024;159:107107.
PubMed Abstract available

LI S, Zhao T, Liu N, Li Y, et al
Global research on oral cancer: A bibliometric analysis based on 82 highly cited publications from 2014 to 2024.
Oral Oncol. 2024;159:107094.
PubMed Abstract available

YANG B, Dai X, Li Z, Wu Z, et al
Noninvasive surface-enhanced Raman spectroscopy outperforms combined positive score in predicting sensitivity to neoadjuvant immunotherapy in head and neck squamous cell carcinoma.
Oral Oncol. 2024;159:107105.
PubMed Abstract available

RENGASAMY G, Priya Veeraraghavan V
Using salivary DNA methylation to predict aging, cell changes, and protein levels for assessing oral mucositis severity and survival in head and neck cancer patients.
Oral Oncol. 2024;159:107086.
PubMed

LEE YC, Hsin LJ, Lin WN, Fang TJ, et al
Robot-assisted versus conventional neck dissection in head and neck cancers: A systematic review and meta-analysis.
Oral Oncol. 2024;159:107101.
PubMed Abstract available

MORGENTHALER J, Trommer M, Khor R, Wada M, et al
Can we safely de-escalate HPV(+) oropharyngeal cancers? - A review of current practices and novel approaches.
Oral Oncol. 2024;159:107089.
PubMed Abstract available

LENNON SILVA CUNHA J
In reply to "Risk of cardiovascular disease among head and neck cancer survivors: A population-based matched cohort study".
Oral Oncol. 2024;159:107096.
PubMed

TOPKAN E, Somay E, Ozturk D, Selek U, et al
Commentary on "Effect analysis of 847 nasopharyngeal carcinoma cases treated with intensity modulated radiation: Experience and suggestions".
Oral Oncol. 2024;159:107099.
PubMed

SHANG K, Li T, Chen Y, Luo X, et al
Gemcitabine plus cisplatin versus docetaxel plus cisplatin and fluorouracil induction chemotherapy combined with locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: A single center prospective phase II clinical trial.
Oral Oncol. 2024;159:107087.
PubMed Abstract available

COSTANTINO A, Haughey B, Alamoudi U, Magnuson JS, et al
Challenges in treating oropharyngeal cancer in the elderly: The role of transoral surgery.
Oral Oncol. 2024;158:106996.
PubMed

SOLARZ P, Mackiewicz-Nartowicz H, Sinkiewicz A, Burduk P, et al
Results of CO2 laser surgery in laryngeal papillomatosis.
Oral Oncol. 2024;158:107004.
PubMed Abstract available

ASHIQUE S, Houshyari M, Islam A, Pal R, et al
The role of microbiota in nasopharyngeal cancer: Where do we stand?
Oral Oncol. 2024;158:106982.
PubMed Abstract available

DE SENA COSTA DE OLIVEIRA D, Cunha JLS
Comment on: Salivary DNA methylation derived estimates of biological aging, cellular frequency, and protein expression as predictors of oral mucositis severity and survival in head and neck cancer patients.
Oral Oncol. 2024;159:107097.
PubMed

HIMANI
Letter to the editor: Burden of oral cancer and associated risk factors at national and state levels: A systematic analysis from the global burden of disease in India, 1990-2021.
Oral Oncol. 2024;159:107093.
PubMed

October 2024

MUTHAMIZH S, Balachandran S, Dilipan E
Opinion on "Tumor habitat-based MRI features assessing early response in locally advanced nasopharyngeal carcinoma".
Oral Oncol. 2024;159:107095.
PubMed

LEHYANTI J, Even C, Fessart E, Wagner-Ballon C, et al
Management of oligometastatic head and neck squamous cell carcinoma: A systematic review.
Oral Oncol. 2024;159:107085.
PubMed Abstract available

VILLARME A, Ebran N, Pace-Loscos T, Schiappa R, et al
Prognostic impact of intra tumoral HPV-16 viral load in oropharyngeal squamous cell carcinomas.
Oral Oncol. 2024;159:107082.
PubMed Abstract available

KARAMCHANDANI S, Sahovaler A, Crosbie-Jones E, McGurk M, et al
Incidence and predictive factors for positive non-sentinel lymph nodes in completion neck dissection following a positive sentinel node biopsy in early oral cancer.
Oral Oncol. 2024;159:107081.
PubMed

LI D, Lopez A, Shrivastava N, Chan W, et al
Comprehensive functional evaluation of head and neck squamous cell carcinoma with BH3-profiling demonstrates apoptotic competency and therapeutic efficacy of BH3-mimetics.
Oral Oncol. 2024;159:107069.
PubMed Abstract available

WU WB, Xia L, Feng ZK, Liang JL, et al
Characteristics and treatment of epistaxis in nasopharyngeal carcinoma.
Oral Oncol. 2024;159:107071.
PubMed Abstract available

ZANG Y, Lu Y, Yu J, Dong Q, et al
FOXP3 inhibits proliferation and migration by competitively inhibiting YAP1 in nasopharyngeal carcinoma.
Oral Oncol. 2024;159:107066.
PubMed Abstract available

GARSET-ZAMANI M, Lomholt AF, Charabi BW, Norling R, et al
Surgeon-performed intraoperative transoral ultrasound improves the detection of human papillomavirus-positive head and neck cancers of unknown primary.
Oral Oncol. 2024;159:107073.
PubMed Abstract available

LIU C, Zhao H, Lu Y, Xia Y, et al
Nomograms to predict occult contralateral central lymph node metastases in unilateral papillary thyroid carcinoma with ipsilateral clinical lymph node metastasis.
Oral Oncol. 2024;159:107051.
PubMed Abstract available

SONG Y, Zhang Y, Bai Y, Wang T, et al
Combination kinase inhibitors and immunotherapy for unresectable anaplastic thyroid carcinoma: A retrospective single-center study.
Oral Oncol. 2024;159:107067.
PubMed Abstract available

AWEEDA M, Richard K, Arnaud EH, Divi V, et al
Factors influencing lymph node yield in head and neck squamous cell carcinoma: A scoping review.
Oral Oncol. 2024;159:107070.
PubMed Abstract available

HE SQ, Liu GY, Yu YH, Wang L, et al
Establishing M1 subdivision for de novo nasopharyngeal carcinoma patients receiving immuno-chemotherapy: A multicenter, retrospective cohort study.
Oral Oncol. 2024;159:107074.
PubMed Abstract available

LEE RH, Evans C, Alqasieer Y, Knott PD, et al
Bite me: Can active biting during trismus therapy improve mouth opening in head and neck cancer patients?
Oral Oncol. 2024;159:107064.
PubMed

ZHAO BY, Hirayama S, Goss D, Zhao Y, et al
Human papillomavirus-associated nasopharyngeal carcinoma: A systematic review and meta-analysis.
Oral Oncol. 2024;159:107057.
PubMed Abstract available

TANG WZ, Xu WZ, Liu TH
Exploring the potential of gemcitabine, capecitabine, and tislelizumab after anti-PD-1 treatment in nasopharyngeal carcinoma.
Oral Oncol. 2024;159:107065.
PubMed

YACOUB I, Qian JY, Nashed K, Youssef M, et al
Radiation techniques and advancements in nasopharyngeal carcinoma.
Oral Oncol. 2024;159:107060.
PubMed

GAUDIOSO P, Contro G, Taboni S, Costantino P, et al
Intraoperative surgical navigation as a precision medicine tool in sinonasal and craniofacial oncologic surgery.
Oral Oncol. 2024;157:106979.
PubMed Abstract available

DAWSON A, Karimi AH, Shaikh MH, Gazala W, et al
Loss of MACROD2 drives radioresistance but not cisplatin resistance in HPV-positive head and neck cancer.
Oral Oncol. 2024;159:107061.
PubMed Abstract available

AKASHANAND, Zahiruddin QS, Jena D, Ballal S, et al
Burden of oral cancer and associated risk factors at national and state levels: A systematic analysis from the global burden of disease in India, 1990-2021.
Oral Oncol. 2024;159:107063.
PubMed Abstract available

September 2024

LECHIEN JR
Surgical, Functional, and oncological outcomes of transoral robotic surgery for cT1-T3 supraglottic laryngeal Cancers: A systematic review.
Oral Oncol. 2024;159:107047.
PubMed Abstract available

KEEFE K, McCrary HC, Wei M, Mark B, et al
Risk of cardiovascular disease among head and neck cancer survivors: A population-based matched cohort study.
Oral Oncol. 2024;159:107041.
PubMed Abstract available

DHARSHINI RAJATHIRAJAN S
Commentary on "Salivary DNA methylation derived estimates of biological aging, cellular frequency and protein expression as predictors of oral mucositis severity and survival in head and neck cancer patients".
Oral Oncol. 2024;159:107053.
PubMed

LYU W, Gong J, Zhu L, Xu T, et al
MR radiomics unveils neoadjuvant chemo-responsiveness with insights into selective treatment de-intensification in HPV-positive oropharyngeal carcinoma.
Oral Oncol. 2024;159:107049.
PubMed Abstract available

PRITHVIRAJ
Comment on "Sexual Health, sexuality and sexual intimacy in patients with head and neck cancer".
Oral Oncol. 2024;159:107054.
PubMed

DINESHKUMAR R
Letter to the editor: Risk factors associated with ototoxicity in long-term survivors of nasopharyngeal carcinoma.
Oral Oncol. 2024;159:107052.
PubMed

VALCENKO A, Zwick A, Schneider L, Linxweiler M, et al
The tumor cell killing capacity of head and neck cancer patient-derived neutrophils depends on tumor stage, gender and the antibody isotype.
Oral Oncol. 2024;159:107042.
PubMed Abstract available

MIN Y, Liu X, Wei Z, Song G, et al
Lung immune prognostic index is associated with clinical outcomes in recurrent or metastatic (R/M) nasopharyngeal carcinoma receiving immunotherapy: Results from the multicenter, single-arm, phase 2 study.
Oral Oncol. 2024;159:107028.
PubMed Abstract available

RENGASAMY G, Priya Veeraraghavan V
Comment on "The prognostic value of image-identified extranodal extension in laryngeal and hypopharyngeal carcinoma following definitive (chemo-) radiotherapy".
Oral Oncol. 2024;159:107035.
PubMed

DHARSHINI RAJATHIRAJAN S
Commentary on "Impact of high-risk EBV strains on nasopharyngeal carcinoma gene expression.".
Oral Oncol. 2024;159:107037.
PubMed

DHARSHINI RAJATHIRAJAN S
Commentary on "Predictive value of CXCL1(+)_FAP(+) phenotype in CAFs for distant metastasis and its correlation with PD-L1 expression in locoregionally advanced nasopharyngeal carcinoma patients".
Oral Oncol. 2024;159:107036.
PubMed

VERSCHOOR CP, Santi SA, Singh R, Tharmalingam S, et al
Salivary DNA methylation derived estimates of biological aging, cellular frequency and protein expression as predictors of oral mucositis severity and survival in head and neck cancer patients.
Oral Oncol. 2024;159:107030.
PubMed Abstract available

PAKA LUBAMBA G, Hua Y, Bao M, Zhang G, et al
Variant of internal jugular vein reconstruction in bilateral radical neck dissection.
Oral Oncol. 2024;159:107015.
PubMed Abstract available

WANG A, Xia H, Li J, Diao P, et al
Development of a novel prognostic signature derived from super-enhancer-associated gene by machine learning in head and neck squamous cell carcinoma.
Oral Oncol. 2024;159:107016.
PubMed Abstract available

PRITHVIRAJ T
Commentary on "Tumor Habitat-Based MRI features assessing early response in locally advanced nasopharyngeal carcinoma".
Oral Oncol. 2024;159:107018.
PubMed

XIAOYU J, Baihong P, Yaozhen L, Shen C, et al
Preoperative protective stenting of the carotid artery in severe complex head and neck cancer resection.
Oral Oncol. 2024;158:107012.
PubMed Abstract available

PAYNE K, Suriyanarayanan H, Brooks J, Mehanna H, et al
Exploring the impact of intra-tumoural heterogeneity on liquid biopsy cell-free DNA methylation and copy number in head and neck squamous cell carcinoma.
Oral Oncol. 2024;158:107011.
PubMed Abstract available

ZHANG X, Zheng W, Huang S, Li H, et al
Xerostomia prediction in patients with nasopharyngeal carcinoma during radiotherapy using segmental dose distribution in dosiomics and radiomics models.
Oral Oncol. 2024;158:107000.
PubMed Abstract available

CHEN J, Cheng H, Liang Y, Lin J, et al
The efficacy of adjuvant chemotherapy in patients with different midpoint-radiotherapy Epstein-Barr virus DNA plasma loads.
Oral Oncol. 2024;156:106938.
PubMed Abstract available

August 2024

LECHIEN JR, Hans S
Survival, Surgical, and functional outcomes of transoral laser microsurgery for cT1-T3 supraglottic laryngeal Cancers: A systematic review.
Oral Oncol. 2024;158:107009.
PubMed Abstract available

ZHAO J, Ruan X, Wei S, Zheng X, et al
The first report of bilateral parapharyngeal lymph node metastasis from papillary thyroid carcinoma: A case report.
Oral Oncol. 2024;158:107006.
PubMed

YIN WJ, Mao W, Yang F, Wang MY, et al
Effect analysis of 847 nasopharyngeal carcinoma cases treated with intensity modulated radiation: Experience and suggestions.
Oral Oncol. 2024;158:107001.
PubMed Abstract available

GE Y, Liu H, Huang W, Zhu H, et al
Immunoinhibitory effects of hypoxia-driven reprogramming of EGR1(hi) and EGR3 positive B cells in the nasopharyngeal carcinoma microenvironment.
Oral Oncol. 2024;158:106999.
PubMed Abstract available

T P
Commentary on "Platinum/taxane/pembrolizumab vs platinum/5FU/pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma (r/mHNSCC)".
Oral Oncol. 2024;158:107010.
PubMed

ZHOU X, Shao T, Jia H, Hou L, et al
Current state, challenges, and future perspective of adaptive radiotherapy: A narrative review of nasopharyngeal carcinoma.
Oral Oncol. 2024;158:107008.
PubMed Abstract available

PRASAD M
DNA Methylation Mediated Epigenetic Silencing of PD-1 and PD-L1: Therapeutic Implications in Oral Cancer.
Oral Oncol. 2024 Aug 23:106995. doi: 10.1016/j.oraloncology.2024.106995.
PubMed

KNAP RABJERG H, Grau Eriksen J, Soby S
Impact of antibiotics on PD-1 inhibition in recurrent/metastatic head and neck squamous cell carcinoma.
Oral Oncol. 2024;158:107003.
PubMed

DU F, Shao K, Yang Y, Bai X, et al
Comparative dosimetric analysis of normal brain tissue in patients with Nasopharyngeal carcinoma at different stages after radiation therapy.
Oral Oncol. 2024;158:106998.
PubMed Abstract available

ALSHEIKH S, Su J, O'Sullivan B, Ringash J, et al
The prognostic value of image-identified extranodal extension in laryngeal and hypopharyngeal carcinoma following definitive (chemo-)radiotherapy.
Oral Oncol. 2024;158:107007.
PubMed Abstract available

SUN L, Cohen RB, Dimitrios Colevas A
Platinum/taxane/pembrolizumab vs platinum/5FU/pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma (r/m HNSCC).
Oral Oncol. 2024;158:106997.
PubMed Abstract available

HANNA GJ, Jabalee J, Lukens JN, Sun L, et al
Circulating tumor tissue modified viral (TTMV)-HPV DNA in Recurrent, metastatic HPV-driven oropharyngeal cancer.
Oral Oncol. 2024;158:107002.
PubMed Abstract available

YUAN J, Wu M, Qiu L, Xu W, et al
Tumor habitat-based MRI features assessing early response in locally advanced nasopharyngeal carcinoma.
Oral Oncol. 2024;158:106980.
PubMed Abstract available

YANG R, Li R, Niu X, Zhao Y, et al
Gemcitabine, capecitabine, and tislelizumab in recurrent/metastatic nasopharyngeal carcinoma following prior anti-PD-1 therapy failure: A retrospective study.
Oral Oncol. 2024;158:106981.
PubMed Abstract available

HUSSEIN NI, Molina AH, Sunga GM, Amit M, et al
Localized intratumoral delivery of immunomodulators for oral cancer and oral potentially malignant disorders.
Oral Oncol. 2024;158:106986.
PubMed Abstract available

PAN GS, Sun XM, Kong FF, Wang JZ, et al
Delta magnetic resonance imaging radiomics features?based nomogram predicts long?term efficacy after induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma.
Oral Oncol. 2024;157:106987.
PubMed Abstract available

QIN G, Liao X, Zhang B, Su Y, et al
An individualized immune prognostic signature in nasopharyngeal carcinoma.
Oral Oncol. 2024;157:106985.
PubMed Abstract available

TAMIOLAKIS P, Shah A, Dawson R, Ramasamy S, et al
HPV- associated sinonasal squamous cell carcinoma with FGFR3::TACC3 fusion. A rare case report.
Oral Oncol. 2024;157:106983.
PubMed Abstract available

SHIMIZU H, Kodaira T, Kiyota N, Hayashi R, et al
Incidence and risk factors associated with the development of hypothyroidism after postoperative chemoradiotherapy for head and neck cancer patients with high-risk features: Supplementary analysis of JCOG1008.
Oral Oncol. 2024;157:106976.
PubMed Abstract available

SANKAR S
Letter to editor regarding "Impact of high-risk EBV strains on nasopharyngeal carcinoma gene expression".
Oral Oncol. 2024;157:106977.
PubMed

SCHAEFFERS AWMA, Scholten HA, van Beers MA, Meussen BW, et al
The effect of skeletal muscle mass on dose-limiting toxicities during (chemo)radiotherapy in patients with head and neck cancer: A systematic review and meta-analysis.
Oral Oncol. 2024;157:106978.
PubMed Abstract available

July 2024

MCDOWELL L, Gough K, White I, Corry J, et al
Sexual Health, sexuality and sexual intimacy in patients with head and neck cancer - A narrative review.
Oral Oncol. 2024;157:106975.
PubMed Abstract available

DAS S, Ghosh Laskar S, V Kane S, D'Cruz AK, et al
Adjuvant therapy for intermediate risk factors in oral cancer: Can we reach a consensus?
Oral Oncol. 2024;157:106972.
PubMed Abstract available

JEYARAJ G
Letter to the editor, "Clinical benefits of combining oral cytotoxic chemotherapeutic agents with radiotherapy in patients with T2N0 glottic squamous cell carcinoma based on the reports of the head and neck Cancer Registry of Japan.".
Oral Oncol. 2024;157:106974.
PubMed

JEYARAJ G
Letter to the editor, "Mutation detection in saliva from oral cancer patients".
Oral Oncol. 2024;157:106929.
PubMed

GANESH PS, Pathoor NN, Gopal RK
Letter to the editor regarding "Induction chemotherapy regimes in first-line treatment for locoregionally advanced nasopharyngeal carcinoma: A network meta-analysis and cost-effectiveness analysis.
Oral Oncol. 2024;157:106954.
PubMed Abstract available

LORINI L, Zigliani G, Morbini P, Salviato E, et al
Expression of PDL-1 between primary and recurrent/metastatic head and neck squamous cell carcinoma: A bi-institutional retrospective concordance analysis (CONCORDL-1 study).
Oral Oncol. 2024;157:106950.
PubMed Abstract available

JEYACHANDRAN S
Comment on, "Characterization of oral microbiota in HPV and non-HPV head and neck squamous cell carcinoma and its association with patient outcomes".
Oral Oncol. 2024;157:106973.
PubMed Abstract available

SURESH S
Comment on: An algorithm for standardization of tumor infiltrating lymphocyte evaluation in head and neck cancers.
Oral Oncol. 2024;157:106959.
PubMed

WEN YF, Huang WJ, Chen XL, Cai HT, et al
Predictive value of CXCL1(+)_FAP(+) phenotype in CAFs for distant metastasis and its correlation with PD-L1 expression in locoregionally advanced nasopharyngeal carcinoma patients.
Oral Oncol. 2024;157:106963.
PubMed Abstract available

ICHISAKA T, Sano D, Kijima N, Kawakita D, et al
Clinical benefits of combining oral cytotoxic chemotherapeutic agents with radiotherapy in patients with T2N0 glottic squamous cell carcinoma based on the reports of the Head and Neck Cancer Registry of Japan.
Oral Oncol. 2024;157:106942.
PubMed Abstract available

TINO R, Roach MA, Fuentes GD, Agrawal A, et al
Development and clinical implementation of a digital workflow utilizing 3D-printed oral stents for patients with head and neck cancer receiving radiotherapy.
Oral Oncol. 2024;157:106944.
PubMed Abstract available

LIM CY, Ng GWY, Goh CK, Lee MKC, et al
Impact of high-risk EBV strains on nasopharyngeal carcinoma gene expression.
Oral Oncol. 2024;157:106941.
PubMed Abstract available

SHANMUGAM G
Letter to the editor, "The prognostic value of pretreatment (18)F-FDG PET-CT parameters with peripheral blood markers in patients with de novo metastatic nasopharyngeal carcinoma.".
Oral Oncol. 2024;157:106951.
PubMed

MEIVELU MOOVENDHAN
"Letter to the Editor: Next-Generation sequencing (NGS) profiling of matched tumor and Circulating Tumor DNA (ctDNA) in Head and Neck Squamous Cell Carcinoma (HNSCC)".
Oral Oncol. 2024;157:106940.
PubMed

ZENGA J, Himburg HA, Wong SJ, Kearl T, et al
In silico identification of public neo-antigens in head and neck Cancer for T cell receptor Engineering: Targeting PI3KCA and TP53 missense mutations.
Oral Oncol. 2024 Jul 14:106947. doi: 10.1016/j.oraloncology.2024.106947.
PubMed

DHARMALINGAM JOTHINATHAN MK
Letter to the Editor, "Immunochemotherapy alone or immunochemotherapy plus subsequent locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma".
Oral Oncol. 2024;156:106948.
PubMed

SHANMUGAM G
Commentary on, "Final analysis of a phase II trial of neoadjuvant chemoimmunotherapy for locoregionally advanced head and neck squamous cell carcinoma.".
Oral Oncol. 2024;156:106952.
PubMed

PIYARATHNE NS, Liyanage SN, Rasnayaka RMSGK, Hettiarachchi PVKS, et al
A comprehensive dataset of annotated oral cavity images for diagnosis of oral cancer and oral potentially malignant disorders.
Oral Oncol. 2024;156:106946.
PubMed Abstract available

MAHDI AGM
Knowledge, and attitude of medical students about role of human papilloma virus, and vaccine in head and neck cancer.
Oral Oncol. 2024;156:106939.
PubMed Abstract available

SHANMUGAM G
Letter to the editor, "Letter to the editor, "Short-term versus long-term metronomic adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma: A propensity score-matched real-world study.".
Oral Oncol. 2024;156:106935.
PubMed

ARUMUGANAINAR D, Sekaran S
Correspondence on "Global burdens of nasopharyngeal carcinoma in children and young adults: Trends and predictions to 2040".
Oral Oncol. 2024;156:106933.
PubMed

GU LW, Zhang X, Zhang J, Xiao BB, et al
The prognostic value of pretreatment (18)F-FDG PET-CT parameters with peripheral blood markers in patients with de novo metastatic nasopharyngeal carcinoma.
Oral Oncol. 2024;156:106928.
PubMed Abstract available

SURESH S
Commentary on 'Mutation detection in saliva from oral cancer patients'.
Oral Oncol. 2024;156:106937.
PubMed

KASIRAJAN H, Rengasamy G, Priya Veeraraghavan V
Comment on the "Quality of life in 583 head and neck cancer survivors assessed with the FACE-Q head and neck cancer module".
Oral Oncol. 2024;156:106934.
PubMed

KANNAN R
Comments on: Human Papilloma Virus vaccine and prevention of head and neck cancer, what is the current evidence?
Oral Oncol. 2024;156:106936.
PubMed

DAUNGSUPAWONG H, Wiwanitkit V
Letter to the Editor on "Utility of TTMV-HPV DNA in resolving indeterminate findings during oropharyngeal cancer surveillance".
Oral Oncol. 2024;156:106930.
PubMed

LIOKATIS P, Liokati I, Obermeier K, Smolka W, et al
Prognostic role of lymph node micrometastasis in oral and oropharyngeal cancer: A systematic review.
Oral Oncol. 2024;154:106808.
PubMed Abstract available

CHEN AM
Translational risk-adapted approaches to de-escalated radiation for human papillomavirus-positive oropharyngeal cancer: Past, present, and future.
Oral Oncol. 2024;154:106850.
PubMed Abstract available

SATHISHKUMAR K
Letter to the editor "risk prediction model for cisplatin-induced acute kidney injury in patients with head and neck cancer receiving chemoradiotherapy: A re-analysis of a phase II/III JCOG1008 trial ".
Oral Oncol. 2024;156:106931.
PubMed

HARIDEVAMUTHU B
Letter to the Editor: "Exploring long-term responses to immune checkpoint inhibitors in recurrent and metastatic head and neck squamous cell Carcinoma".
Oral Oncol. 2024;156:106913.
PubMed

June 2024

BENJAMIN WJ, Feng AL, Heft Neal M, Bellile E, et al
Utility of bioselection with neoadjuvant chemotherapy for organ preservation in patients with T4 laryngeal cancer.
Oral Oncol. 2024;156:106917.
PubMed Abstract available

ZHAO X, Zhou Y, Peng G, Wen L, et al
Final analysis of a phase II trial of neoadjuvant chemoimmunotherapy for locoregionally advanced head and neck squamous cell carcinoma.
Oral Oncol. 2024;156:106918.
PubMed Abstract available

SARAVANAN M, Singh Carmelin D, Mohanprasanth A, Arockiaraj J, et al
Comment on "Oral microbiome and risk of incident head and neck cancer: A nested case-control study".
Oral Oncol. 2024;156:106911.
PubMed

POONGAVANAM SS, Behera A, Dharmalingam Jothinathan MK
Letter to the editor, "Proton therapy re-irradiation outcomes and genomic landscape of patients with recurrent head and neck cancer".
Oral Oncol. 2024;156:106912.
PubMed

JEYARAJ G
Letter to the editor, "Immune infiltration at the primary tumor is associated with clinical outcome of patients with extranodal extension of lymph node metastasis in oral cancer".
Oral Oncol. 2024;156:106906.
PubMed

DONG S, Bei W, Lin L, Jiang Y, et al
Short-term versus long-term metronomic adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma: A propensity score-matched real-world study.
Oral Oncol. 2024;156:106908.
PubMed Abstract available

JEYARAJ G
Transformative impact of 3D-Printed implants and Virtual surgical planning in oral cancer reconstruction.
Oral Oncol. 2024;156:106896.
PubMed

SHANMUGAM G
Letter to the editor, "Proton therapy re-irradiation outcomes and genomic landscape of patients with recurrent head and neck cancer.".
Oral Oncol. 2024;156:106915.
PubMed

BASTIEN AJ, Ng J, Cong I, Garcia J, et al
Patient perceptions underlying ctDNA molecular surveillance for HPV(+) oropharyngeal squamous cell carcinoma.
Oral Oncol. 2024;156:106894.
PubMed Abstract available

HARIDEVAMUTHU B
Letter to the Editor: "Immune infiltration at the primary tumor is associated with clinical outcome of patients with extranodal extension of lymph node metastasis in oral Cancer".
Oral Oncol. 2024;155:106902.
PubMed

MEIVELU MOOVENDHAN
Letter to the editor, "Gut microbiome predicts gastrointestinal toxicity outcomes from chemoradiation therapy in patients with head and neck squamous cell carcinoma".
Oral Oncol. 2024;155:106903.
PubMed

PRASAD M, Sekar R, Murugan R
Letter to editor on "Proton therapy re-irradiation outcomes and genomic landscape of patients with recurrent head and neck cancer".
Oral Oncol. 2024;155:106899.
PubMed

SELVI POONGAVANAM S, Behera A, Kumar Dharmalingam Jothinathan M
Letter to the Editor, "The predictive role of PD-L1 in head and neck Cancer: A systematic review and Meta-Analysis".
Oral Oncol. 2024;155:106904.
PubMed

TOPKAN E, Somay E, Bascil S, Selek U, et al
Comment on prospective comparison of acute severe toxicities between smokers and non-smokers during radiotherapy for head and neck cancers.
Oral Oncol. 2024;155:106898.
PubMed

HARIDEVAMUTHU B
Genomic instability in HPV-positive oropharyngeal squamous cell carcinoma: The role of integration sites in treatment response.
Oral Oncol. 2024;155:106895.
PubMed

LEI S, Chen L, Ji P, Li K, et al
Global burdens of nasopharyngeal carcinoma in children and young adults and predictions to 2040.
Oral Oncol. 2024;155:106891.
PubMed Abstract available

DA MOTA SANTANA LA, Simoes JMD, Santos GA, Gopalsamy RG, et al
Comment on "Association between COVID 19 exposure and expression of malignant pathological features in oral cancer: A retrospective cohort study".
Oral Oncol. 2024;155:106877.
PubMed

ROOF SA, Jabalee J, Rettig EM, Chennareddy S, et al
Utility of TTMV-HPV DNA in resolving indeterminate findings during oropharyngeal cancer surveillance.
Oral Oncol. 2024;155:106874.
PubMed Abstract available

FERRARI M, Mularoni F, Taboni S, Crosetti E, et al
Corrigendum to "How reliable is assessment of true vocal cord-arytenoid unit mobility in patients affected by laryngeal cancer? a multi-institutional study on 366 patients from the ARYFIX collaborative group" [Oral Oncol. 152C (2024) 106744].
Oral Oncol. 2024 Jun 8:106887. doi: 10.1016/j.oraloncology.2024.106887.
PubMed

PRASAD M, Murugan R
Comment on "The circadian clock gene, BMAL1, promotes radiosensitization in nasopharyngeal carcinoma by inhibiting the epithelial-to-mesenchymal transition via the TGF-beta1/Smads/Snail1 axis".
Oral Oncol. 2024;155:106890.
PubMed

TASOULAS J, Adams GJ, Schrank TP, Agala CB, et al
Time to treatment for head and neck cancer patients decreased during the early phase of the Covid-19 pandemic.
Oral Oncol. 2024;155:106879.
PubMed

DHARMALINGAM JOTHINATHAN MK
Letter to the Editor, "How reliable is assessment of true vocal cord-arytenoid unit mobility in patients affected by laryngeal cancer? A multi-institutional study on 366 patients from the ARYFIX collaborative group".
Oral Oncol. 2024;155:106878.
PubMed

BABU S, Krishnan M
Human papillomavirus and oropharyngeal cancer in HNSCC: A growing concern.
Oral Oncol. 2024;153:106824.
PubMed

PACE GM, Costantino A, Festa BM, Spriano G, et al
Oropharyngeal squamous cell carcinoma: Treatment (de-) intensification?
Oral Oncol. 2024;153:106299.
PubMed

LU HA, Wang YM, Chih Chen W, Wu CN, et al
Post-irradiation dysbiosis in patients with nasopharyngeal carcinoma having received radiotherapy - A pilot study.
Oral Oncol. 2024;154:106864.
PubMed Abstract available

KRC R, Mendes W, Molitoris J, Ferris M, et al
Proton therapy re-irradiation outcomes and genomic landscape of patients with recurrent head and neck cancer.
Oral Oncol. 2024;154:106875.
PubMed Abstract available

May 2024

XU W, Qiu L, Li F, Fei Y, et al
Induction chemotherapy regimes in first-line treatment for locoregionally advanced nasopharyngeal carcinoma: A network meta-analysis and cost-effectiveness analysis.
Oral Oncol. 2024;154:106865.
PubMed Abstract available

IMAMURA Y, Kiyota N, Tahara M, Kodaira T, et al
Risk prediction model for cisplatin-induced acute kidney injury in patients with head and neck cancer receiving chemoradiotherapy: A re-analysis of a phase II/III JCOG1008 trial.
Oral Oncol. 2024;154:106868.
PubMed Abstract available

PARK R, Li J, Slebos RJC, Chaudhary R, et al
Phase Ib trial of IRX-2 plus durvalumab in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.
Oral Oncol. 2024;154:106866.
PubMed Abstract available

SARAVANAN M, Carmelin DS, Mohanprasanth A, Arockiaraj J, et al
Comment on "Oral microbiome and risk of incident head and neck cancer: A nested case-control study".
Oral Oncol. 2024;154:106858.
PubMed

HESHAM A, David Kim D, Alshamrani Y, AlOtaibi F, et al
The efficacy of docetaxel, cisplatin, and 5-fluorouracil chemotherapy in recurrent head and neck squamous cell carcinoma. Report of a case and review of the literature.
Oral Oncol. 2024;154:106863.
PubMed

ABBACI M, Villard A, Auperin A, Asmandar S, et al
Ultra-fast confocal fluorescence microscopy for neck lymph node imaging in head and neck cancer.
Oral Oncol. 2024;154:106862.
PubMed Abstract available

YAO Y, Ouyang Q, Wang S, Li K, et al
Incorporation of PD-1 blockade into induction chemotherapy improved tumor response in patients with locoregionally advanced nasopharyngeal carcinoma in a retrospective patient cohort.
Oral Oncol. 2024;154:106867.
PubMed Abstract available

RICARDO ELIAS DE MELO P, Agra Monteiro M, Vitoria de Araujo Lopes N, Silva Cunha JL, et al
In response to the reply on 'Advancing oral cancer diagnosis in Brazil: Integrating artificial intelligence with teledentistry for enhanced patient outcomes'.
Oral Oncol. 2024;154:106856.
PubMed

COSTANTINO A, Haughey B, Zhu J, Mekhail T, et al
Sinonasal squamous cell carcinoma in the United States: Temporal and geographic patterns associated with HPV testing and positivity.
Oral Oncol. 2024;154:106855.
PubMed Abstract available

PEZZULLA D, Re A, Ferro M, Cilla S, et al
Lower cranial nerve palsy after hypofractionated radiotherapy in a laryngeal cancer patient: A letter to the editor.
Oral Oncol. 2024;154:106837.
PubMed

ALVES DA MOTA SANTANA L, Gois Floresta L, Maciel Alves EV, Ribeiro Couto G, et al
Reply to: Comment on "Advancing oral cancer diagnosis in Brazil: Integrating artificial intelligence with teledentistry for enhanced patient outcomes".
Oral Oncol. 2024;154:106840.
PubMed

HE S, Yu H, He L, Liu M, et al
Risk factors associated with ototoxicity in long-term nasopharyngeal carcinoma survivors.
Oral Oncol. 2024;154:106827.
PubMed Abstract available

VAZQUEZ FL, Coracin FL, Arantes KLBF, Ferigatto JL, et al
An oral cancer screening program in Brazil: Analysis of seven years of outcome after its implementation in the suburban cities of Sao Paulo.
Oral Oncol. 2024;154:106826.
PubMed Abstract available

DE FELICE F, Guerrero Urbano T
Lower-neck sparing in patients with uninvolved neck nasopharyngeal carcinoma: Unquestioned benefit?
Oral Oncol. 2024;154:106836.
PubMed

HAN N, Zhou D, Ruan M, Yan M, et al
Corrigendum to "Cancer cell-derived extracellular vesicles drive pre-metastatic niche formation of lymph node via IFNGR1/JAK1/STAT1-activated-PD-L1 expression on FRCs in head and neck cancer" [Oral Oncol. 145 (2023) 106524].
Oral Oncol. 2024 May 9:106831. doi: 10.1016/j.oraloncology.2024.106831.
PubMed

INVERNIZZI C, Da Silva Ribeiro Mota A, Barbe C, Bouazzi L, et al
Prospective comparison of acute severe toxicities between smokers and non-smokers during radiotherapy for head and neck cancers.
Oral Oncol. 2024;153:106833.
PubMed Abstract available

PADERNO A, Petrelli F, Lorini L, Capriotti V, et al
The predictive role of PD-L1 in head and neck cancer: A systematic review and meta-analysis.
Oral Oncol. 2024;153:106799.
PubMed Abstract available

LIU Y, Zuo ZC, Zeng XY, Ma J, et al
Establishing subdivisions of M1 stage nasopharyngeal carcinoma based on decision tree classification: A multicenter retrospective study.
Oral Oncol. 2024;153:106834.
PubMed Abstract available

XU Y, Xu T, Yao Q, Chen J, et al
Individualized radiology screening for newly diagnosed nasopharyngeal carcinoma.
Oral Oncol. 2024;153:106828.
PubMed Abstract available

ALMANGUSH A, Makitie AA, Leivo I
Assessment of tumor-infiltrating lymphocytes in head and neck cancer: Clinical scenarios.
Oral Oncol. 2024;153:106829.
PubMed

DAS R, Misra SR
Author's reply to comment on "awareness regarding oral cancer amongst the dental, medical, and nursing students: Is something lacking?".
Oral Oncol. 2024;153:106832.
PubMed

DHARMALINGAM JOTHINATHAN MK
Outcomes of transoral robotic surgery for early-stage oropharyngeal squamous cell carcinoma with low rates of adjuvant therapy: A consecutive single-institution study from 2013 to 2020.
Oral Oncol. 2024;152:106811.
PubMed

POOJARI M, Madabhavi I, Desai S
Extraskeletal Ewing's sarcoma of supraglottis: A rare case report.
Oral Oncol. 2024;152:106789.
PubMed Abstract available

MELDGAARD JUSTESEN M, Kronberg Jakobsen K, Fenger Carlander AL, Hjordt Holm Larsen M, et al
Outcomes of transoral robotic surgery for early-stage oropharyngeal squamous cell carcinoma with low rates of adjuvant therapy: A consecutive single-institution study from 2013 to 2020.
Oral Oncol. 2024;152:106783.
PubMed Abstract available

April 2024

TONSBEEK AM, Hundepool CA, Roubos J, Rijken B, et al
Quality of life in 583 head and neck cancer survivors assessed with the FACE-Q head and neck cancer module.
Oral Oncol. 2024;153:106813.
PubMed Abstract available

MICHIKAWA C, Gleber-Netto FO, Pickering CR, Rao X, et al
Immune infiltration at the primary tumor is associated with clinical outcome of patients with extranodal extension of lymph node metastasis in oral cancer.
Oral Oncol. 2024;153:106729.
PubMed Abstract available

FANG Q, Yuan J, Zhang X, Dai L, et al
Oncologic and functional results between sentinel lymph node biopsy and elective neck dissection in cT1/2N0 maxillary squamous cell carcinoma.
Oral Oncol. 2024;152:106810.
PubMed Abstract available

YEO BSY, Lee RS, Lim NE, Tan E, et al
Efficacy and Safety of Cell-based Immunotherapy in The Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma - A Systematic Review and Meta-analysis.
Oral Oncol. 2024;152:106786.
PubMed Abstract available

LI Y, Zhou Y, Zhao C, Liu L, et al
The circadian clock gene, BMAL1, promotes radiosensitization in nasopharyngeal carcinoma by inhibiting the epithelial-to-mesenchymal transition via the TGF-beta1/Smads/Snail1 axis.
Oral Oncol. 2024;152:106798.
PubMed Abstract available

RAMASAMY P, Sekaran S, Ganapathy D
Oral cancer burden in tribal populations residing in India.
Oral Oncol. 2024;152:106801.
PubMed

SEKAR D
Comment on betel-nut chewing does not influence PD-L1 expression rates in recurrent/metastatic head and neck squamous cell carcinoma (HNSCC): A prospective biomarker prevalence study.
Oral Oncol. 2024;152:106800.
PubMed

SARAVANAN M
Comment on "Nanomedicine, an emerging therapeutic strategy for oral cancer therapy".
Oral Oncol. 2024;152:106806.
PubMed

RICARDO ELIAS DE MELO P, Agra Monteiro M, Henrique Rocha Aragao H, Vitoria de Araujo Lopes N, et al
Comment on "Awareness regarding oral cancer amongst the dental, medical, and nursing students: Is something lacking?".
Oral Oncol. 2024;152:106802.
PubMed

SMITH JD, Heft-Neal ME, Rosko AJ, Chepeha DB, et al
Upfront neck dissection to guide single-modality therapy for early stage supraglottic squamous cell carcinoma.
Oral Oncol. 2024;152:106803.
PubMed

KONO M, Saito S, Rokugo M, Egloff AM, et al
Enhanced oral versus flank lymph node T cell response parallels anti-PD1 efficacy in head and neck cancer.
Oral Oncol. 2024;152:106795.
PubMed Abstract available

SEGNA E, Civita F, Denaro N, Beltramini GA, et al
Cavernous sinus metastasis in head and neck cancer: Focus on oral squamous cell cancer.
Oral Oncol. 2024;152:106784.
PubMed Abstract available

SIVAPERUMAL P, Ganapathy D, Kamala K
Revolutionizing oral cancer treatment: Harnessing the potential of adaptive CARneg T cell therapy.
Oral Oncol. 2024;152:106794.
PubMed

RAJAKUMAR HK, Coimbatore Sathyabal V, Vivekanandam A, Nasrin Jabarulla K, et al
Evaluation of nuclear morphometry in exfoliative cytology of buccal mucosa in patients with high risk of oral cancer.
Oral Oncol. 2024;152:106793.
PubMed Abstract available

SARAVANAN M
Comment on "The microbiome and oral cancer: More questions than answers".
Oral Oncol. 2024;152:106792.
PubMed

ARAGAO HHR, Monteiro MA, Lopes NVA, Cunha JLS, et al
Comment on "Betel-nut chewing does not influence PD-L1 expression rates in recurrent/metastatic head and neck squamous cell carcinoma (HNSCC): A prospective biomarker prevalence study".
Oral Oncol. 2024;152:106788.
PubMed

DAS R, Misra SR, Nayak A
Awareness regarding oral cancer amongst the dental, medical, and nursing students: Is something lacking?
Oral Oncol. 2024;152:106790.
PubMed

XIAO X, Shi Z, Song Z
Comment on circulatory mitochondrial DNA as a novel biomarker for head and neck cancers.
Oral Oncol. 2024;152:106785.
PubMed

GASNE C, Atallah S, Dauzier E, Thariat J, et al
Twelve years after: The french national network on rare head and neck tumours (REFCOR).
Oral Oncol. 2024;151:106762.
PubMed Abstract available

MALI SB
Role of telemedicine in head neck cancer.
Oral Oncol. 2024;151:106746.
PubMed Abstract available

MIRIMOGHADDAM M, Bohlouli B, Lai H, Viegas S, et al
Trends and predictors of unplanned hospitalization among oral and oropharyngeal cancer patients; an 8-year population-based study.
Oral Oncol. 2024;151:106742.
PubMed Abstract available

March 2024

MEGAHED R, Prabhu AV, Mack DP, Gholami S, et al
Re-irradiation of recurrent head and neck cancers using pulsed reduced dose rate radiotherapy: An institutional series.
Oral Oncol. 2024;152:106778.
PubMed Abstract available

LORINI L, Gili R, Salvestrini V, Morelli I, et al
De novo metastatic head and neck squamous cell carcinoma: Why does locoregional control "always" matter?
Oral Oncol. 2024;152:106768.
PubMed Abstract available

XIROU V, Moutafi M, Bai Y, Nwe Aung T, et al
An algorithm for standardization of tumor Infiltrating lymphocyte evaluation in head and neck cancers.
Oral Oncol. 2024;152:106750.
PubMed Abstract available

HONG RL, Yen CJ, Lien MY, Cheng R, et al
Betel-nut chewing does not influence PD-L1 expression rates in recurrent/metastatic head and neck squamous cell carcinoma (HNSCC): A prospective biomarker prevalence study.
Oral Oncol. 2024;152:106760.
PubMed Abstract available

FERRARI M, Mularoni F, Taboni S, Crosetti E, et al
How reliable is assessment of true vocal cord-arytenoid unit mobility in patients affected by laryngeal cancer? a multi-institutional study on 366 patients from the ARYFIX collaborative group.
Oral Oncol. 2024;152:106744.
PubMed Abstract available

TOYA R, Fukugawa Y, Saito T, Matsuyama T, et al
Radiation Therapy Oncology Group 8502 "QUAD shot" regimen using volumetric modulated arc therapy for incurable head and neck cancer.
Oral Oncol. 2024;151:106752.
PubMed Abstract available

RUIZ-TORRES DA, Naegele S, Podury A, Wirth L, et al
Immunotherapy time of infusion impacts survival in head and neck cancer: A propensity score matched analysis.
Oral Oncol. 2024;151:106761.
PubMed Abstract available

SIMON L, Paly J, Park E, Samuels-Kalow M, et al
Medicare dental coverage for patients with head and neck cancer: An opportunity in need of advocates.
Oral Oncol. 2024 Mar 15:106754. doi: 10.1016/j.oraloncology.2024.106754.
PubMed

RICARDO ELIAS DE MELO P, Agra Monteiro M, Vitoria de Araujo Lopes N, Silva Cunha JL, et al
Comment on "advancing oral cancer diagnosis in Brazil: Integrating artificial intelligence with Teledentistry for Better Patient Outcomes".
Oral Oncol. 2024;151:106758.
PubMed

RAJANATHADURAI J, Sindya J, Madar IH, Perumal E, et al
Exosomal immune checkpoint protein (PD-L1): Hidden player in PD-1/PD-L1 blockade immunotherapy resistance in oral cancer.
Oral Oncol. 2024;151:106748.
PubMed

ZUPANCIC M, Kostopoulou ON, Holzhauser S, Lukoseviciute M, et al
Human papillomavirus (HPV) load is higher in HPVDNA/p16 positive than in HPVDNA positive/p16 negative oropharyngeal squamous cell carcinoma but does not differ significantly between various subsites or correlate to survival.
Oral Oncol. 2024;151:106749.
PubMed Abstract available

FERRARO T, Pershad AR, Arora S, Lee E, et al
The utility of ultrasonographic surveillance in management of a presumed branchial cleft cyst later confirmed HPV-associated oropharyngeal cancer.
Oral Oncol. 2024;151:106743.
PubMed Abstract available

KIM DH, Lim ST, Kim HR, Kang EJ, et al
Impact of PIK3CA and cell cycle pathway genetic alterations on durvalumab efficacy in patients with head and neck squamous cell carcinoma: Post hoc analysis of TRIUMPH study.
Oral Oncol. 2024;151:106739.
PubMed Abstract available

SANTANA LADM, Floresta LG, Alves EVM, Melo LMR, et al
Advancing oral cancer diagnosis in Brazil: Integrating artificial intelligence with teledentistry for enhanced patient outcomes.
Oral Oncol. 2024;151:106741.
PubMed

CHEN K, Shi M, Mo S, Liu T, et al
Clinical features and prognostic factors of nasopharyngeal carcinoma with brain metastases.
Oral Oncol. 2024;151:106738.
PubMed Abstract available

DING C, Dai DY, Luo ZK, Wang GY, et al
Evaluation of a novel model incorporating serological indicators into the conventional TNM staging system for nasopharyngeal carcinoma.
Oral Oncol. 2024;151:106725.
PubMed Abstract available

LU X, Zhang JL, Zhai X, Liu Q, et al
A case report on a nasal and oral cavity involving large solitary fibrous tumor and comprehensive review of case literature.
Oral Oncol. 2024;150:106715.
PubMed Abstract available

YOUNG RJ, Angel C, Bressel M, Pizzolla A, et al
Characterising B cell expression and prognostic significance in human papillomavirus positive oropharyngeal cancer.
Oral Oncol. 2024;150:106687.
PubMed Abstract available

February 2024

VAN SCHAIK JE, van der Vegt B, Slagter-Menkema L, van der Laan BFAM, et al
Identification of new head and neck squamous cell carcinoma molecular imaging targets.
Oral Oncol. 2024;151:106736.
PubMed Abstract available

MELACHURI M, Kurukulasuriya C, Rumde P, Patel T, et al
Treatment package time < 14 weeks improves recurrence free and disease specific survival in HPV positive OPC with high-risk features.
Oral Oncol. 2024;151:106703.
PubMed Abstract available

AHMED AA, Sborchia M, Bye H, Roman-Escorza M, et al
Mutation detection in saliva from oral cancer patients.
Oral Oncol. 2024;151:106717.
PubMed Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Otorhinolaryngology is free of charge.